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1 General Introduction 
 
1.1 Salmonella taxonomy and characteristics 
 
Salmonella is a genus of rod-shaped, Gram-negative bacteria belonging to the family 
Enterobacteriaceae. They are non-spore forming, facultative anaerobes and often possess 
peritrichous flagellae for motility. Salmonellae are commonly found pathogens because most 
have a broad spectrum of hosts (both warm- and cold blooded organisms) and transmission 
vectors (food, feed, water sources, farm material and animals such as rodents). Additionally, 
they are capable of surviving in the environment for prolonged periods of time. They are 
able to multiply when temperatures range between 7 - 45 °C and when pH is ranging 
between 4.0 and 9.5. Additionally, they are able to survive freezing temperatures and 
dehydration. Therefore, these zoonotic bacteria are frequently found in the environment 
and in animals, and are of importance because they can cause severe illnesses depending on 
the serotype and host. 
 
The genus Salmonella consists of only two species, namely Salmonella enterica and 
Salmonella bongori. Salmonella enterica is further sub-divided in six subspecies: enterica, 
salamae, arizonae, diarizonae, houtenae and indica [1]. Together, these six subspecies of S. 
enterica and S. bongori comprise more than 2600 characterized serotypes or serovars [2]. 
Salmonella serovars are divided according to the White-Kauffmann-Le Minor scheme, which 
is based on the presence and structure of different surface antigens. The antigens that 
define the serotype are the ‘O’ antigen, which is determined by the oligosaccharide type of 
lipopolysaccharide (LPS), the ‘H’ antigen, determined by flagellar proteins and the capsular 
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‘Vi’ antigen. The Salmonella serovars can be further divided based on their susceptibility to 
antimicrobials or bacteriophages. With the latter method, different phage types (DT) can be 
distinguished within certain serotypes [3].  
 
Most Salmonella serovars of zoonotic importance belong to Salmonella enterica subsp. 
enterica [1, 4] and are capable of causing disease in a broad range of hosts, such as 
Salmonella Enteritidis and Salmonella Typhimurium. Other Salmonella serotypes, like 
Salmonella Typhi in humans and Salmonella Gallinarum in chickens, are adapted to a single 
host species and only cause disease in their respective hosts. 
 
1.2 Salmonella in humans 
 
In 2012, 91 034 confirmed cases of human salmonellosis were reported in the European 
Union, with a notification rate of 22.2 cases per 100 000 population [5, 6]. The estimated 
case-fatality rate for Salmonella was reported to be 0.14 %, as 61 deaths occurred due to 
non-typhoidal salmonellosis. This is however an underestimation of the real number of 
human salmonellosis cases as not all infected people develop symptoms, not all infected 
persons are sampled and because it is not obliged to report positive samples to public health 
authorities. While the number of human salmonellosis cases has been decreasing since 2008 
(with 32 % fewer cases in 2012), Salmonella remains the second most frequently reported 
zoonotic agent in humans in the European Union (Figure 1) [5]. The decrease in human 
salmonellosis cases is often attributed to the successful Salmonella control programs in 
laying hens, which resulted in a lower occurrence of Salmonella in eggs and consequently in 
a reduced introduction of Salmonella in the food chain. Campylobacteriosis was however the 
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most frequently reported human zoonosis in the European Union in 2012 with more than 
double the number of reported Salmonella cases, illustrating the importance of 
Campylobacter for human health as well [5]. 
 
 
Figure 1: The number of confirmed human cases for different zoonoses in the EU in 2012 (adapted from [5]). 
 
Salmonella enterica subsp. enterica serovar Enteritidis (more commonly known as 
Salmonella Enteritidis) was the most prevalent serovar isolated from humans in 2012, with 
41.3% of all human Salmonella isolates belonging to this serovar [5]. The second most 
isolated serovar was Salmonella enterica subsp. enterica serovar Typhimurium (Salmonella 
Typhimurium), to which 22.1 % of all human isolates belonged. Monophasic Salmonella 
Typhimurium 1,4,[5],12:i:- was reported to be the third most prevalent serovar due to 
several large outbreaks, followed by Salmonella Infantis (Figure 2). 
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Figure 2: Distribution of the Salmonella serovars found in humans in the EU in 2012 [5]. 
 
Human salmonellosis, when not asymptomatically, is usually characterized by acute onset of 
fever, abdominal pain, nausea and sometimes vomiting, after an incubation period of 12-36 
hours. These symptoms are often mild and infections are frequently self-limiting, lasting only 
a few days. However, this is not always the case, and in some patients (especially the YOPI 
group; Young, Old, Pregnant and Immunosuppressed) this infection can become more 
serious and the associated dehydration can become life-threatening. When this is the case, 
and when Salmonella causes systemic infections, antimicrobials are necessary for treatment. 
However, rehydration and electrolyte supplementation therapy may be more appropriate 
when suffering from severe diarrhea, as excessive use of antimicrobials has resulted in an 
increase in microbial resistance [7, 8], limiting therapeutic alternatives. Additionally, 
antimicrobial treatment does not shorten the symptomatic period and might even prolong 
the duration of carriage [9]. Consequently, antibiotics should be reserved for patients at 
increased risk or suffering from severe disease. 
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1.3 Salmonella in food and food products 
 
Despite the decreasing number of human salmonellosis cases, Salmonella remains the 
zoonotic agent responsible for most food borne outbreaks in the European Union in 2012. It 
caused 28.6 % of all food-borne outbreaks, while bacterial toxins, viruses and Campylobacter 
(the other major causative agents) caused only 14.5 %, 14.1 % and 9.3 % of all foodborne 
outbreaks respectively (Figure 3). Humans can also become infected with Salmonella 
through direct or indirect contact with animals [10], but most human salmonellosis cases are 
caused by the consumption of contaminated food. In order to reduce the prevalence of 
Salmonella in food and food products, the European Union laid down Regulation (EC) No 
2073/2005, which was modified by Regulation (EC) No 1441/2007. These regulations 
describe rules for sampling and testing food and food products and set limits for the 
presence of Salmonella in different food categories and in samples derived from food 
processing. More specifically, they describe that Salmonella must be absent from several 
food categories, such as minced meat and meat preparations intended to be eaten raw, milk 
and whey powder, ice cream and egg products. Absence of Salmonella is determined by 
testing five or 30 samples of 25 g per batch, depending on the food category. 
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Figure 3: Distribution of food-borne outbreaks per causative agent in the EU in 2012 [5]. 
 
Salmonella can be found in different types of food, ranging from poultry, pig and bovine 
products and meat to vegetables, fish or other fishery products. It is most frequently found 
in fresh broiler meat and turkey meat, less often in pig or bovine meat and rarely in table 
eggs [5]. However, because table eggs are consumed in large quantities, this low prevalence 
also remains relevant for consumer food safety [5]. Similarly, Salmonella contaminated pig 
meat and derived products are an important source of food-borne salmonellosis as well. 
Salmonella could be found in 0.7 % of the tested pig meat in the European Union in 2012, 
and pig meat and products thereof are believed to be responsible for 5.8 % of all strong-
evidence Salmonella outbreaks [5]. Minced meat and meat preparations from poultry 
however have the highest level of non-compliance with EU Salmonella criteria, with 8.7 % of 
single samples and 5.7 % of batches being positive for Salmonella in 2012 [5]. Additionally, 
the highest proportions of Salmonella-positive single samples were reported for fresh broiler 
meat at an average level of 5.5 % [5]. Consequently, broiler meat is an important source of 
foodborne Salmonella outbreaks and efforts should be made to reduce the amount of 
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Salmonella in broiler meat and derived products. These efforts should focus on the whole 
broiler meat production chain and the subsequent storage and handling of meat. A key part 
in this ‘farm-to-fork’ strategy would be to reduce Salmonella prevalence in poultry flocks, 
which in turn would result in a reduced prevalence of Salmonella in poultry products. This 
could possibly be done by exploiting a colonization-inhibition (CI) phenomenon, which is 
currently not used in practice but represents a potentially powerful method to reduce 
Salmonella prevalence in poultry flocks. Therefore, several aspects of this CI phenomenon as 
a possible novel control method to reduce Salmonella colonization of poultry will be 
investigated in this work. 
 
1.4 Salmonella in animals other than chickens 
 
In addition to chickens, pigs represent an important reservoir for Salmonella as well. In 2012, 
5.5 % of all tested pigs and 17.5 % of all tested herds in Europe were positive for Salmonella 
[5]. In Belgium, 10.8 % of all tested pig carcasses in the slaughterhouse were positive for 
Salmonella [5]. Salmonella Typhimurium was the serovar most commonly isolated from pigs 
and pig meat in Europe in 2011, followed by Salmonella Derby and monophasic Salmonella 
Typhimurium [11]. Similarly, in Belgium, Salmonella Typhimurium was the Salmonella 
serovar most commonly associated with pigs, with 67.5 % of tested strains being Salmonella 
Typhimurium isolates in 2010 [12]. Salmonella Derby was the second most prevalent 
serotype in pigs in Belgium in 2010, with 7.3 % of tested strains belonging to this serotype 
[12]. 
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Salmonella can also be found in other animals, such as cattle, turkeys, ducks and geese. In 
2012 in Europe, 2.3 % of all tested cattle and 3.8 % of all tested herds were positive for 
Salmonella [5]. The overall prevalence for Salmonella in fattening turkey flocks in the 
European Union was 0.4 %, a prevalence similar to that in 2011 (0.5 %) [5]. Consequently, 
these animals represent a reservoir for Salmonella as well and contribute to the introduction 
of Salmonella in the food chain. However, as Salmonella contaminated eggs, pig meat, 
broiler meat and derived products are far more important for human health, efforts to 
control Salmonella in the food chain should mainly focus on chickens and pigs. 
 
1.5 Salmonella in chickens 
 
1.5.1 Epidemiology 
 
In 2012, 0.4 % of Gallus gallus breeding flocks were positive for either Salmonella Enteritidis, 
Salmonella Typhimurium, Salmonella Hadar, Salmonella Infantis or Salmonella Virchow, the 
serovars covered by European legislation in breeders [5]. Overall, 2.0 % of the breeding 
flocks of Gallus gallus in the European Union were positive for Salmonella spp in 2012, which 
is a small increase since 2011 when 1.9 % were found positive [5]. In Belgium, 2.5 % of Gallus 
gallus breeding flocks were positive for Salmonella spp in 2012 and 0.2 % were positive for 
the target serovars covered by European legislation [5]. In the case of laying hens, the 
prevalence of Salmonella Enteritidis and Salmonella Typhimurium reduced from 1.5 % in 
2011 to 1.3 % in 2012 in Europe [5]. Altogether, 3.2 % and 4.7 % of the laying hen flocks 
were positive for Salmonella spp in Europe and Belgium respectively [5]. A similar prevalence 
was observed in broilers in Europe, where 3.1 % of all flocks were positive for Salmonella spp 
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in 2012. This was a decrease of 0.1 % since 2011. In Belgium, 3.4 % of all broiler flocks were 
positive for Salmonella spp in 2012. The prevalence for the serovars covered by European 
legislation in broilers, Salmonella Enteritidis and Salmonella Typhimurium, was 0.3 % in 
Europe and 0.6 % in Belgium [5]. The prevalence of these two serotypes in broilers is thus 
quite low, but Salmonella Enteritidis and Typhimurium remain relevant in broilers due to 
their importance for human health. The prevalence of Salmonella in poultry has, in general, 
been decreasing the past few years, and this decrease is mainly due to implemented control 
programs. As of 2009, European Union member states are obliged to implement national 
programs to control Salmonella in broiler flocks in accordance with Regulation (EC) No 
2160/2003. This Regulation states that measures should be taken to prevent, detect and 
control Salmonella at all relevant stages of the production, processing and distribution chain 
in order to reduce Salmonella prevalence and thus the risk to public health. Legislation in the 
European Union dictates that the maximum percentage of broiler flocks positive for the 
serovars Enteritidis and Typhimurium should be 1 % or less, because of their importance for 
human health. Sampling of broiler flocks takes place 3 weeks before the chickens are moved 
to the slaughterhouse, by taking at least two pairs of overshoe samples per flock. 
 
In addition to the staggering evidence linking consumption of contaminated poultry products 
to salmonellosis cases, the presence of different serotypes of importance for public health in 
poultry flocks indicates that poultry is an important reservoir for human infections. 
Vaccinating layers, which is mandatory in Belgium since 2007 [13], has resulted in a lower 
Salmonella Enteritidis prevalence in egg and egg products, which in turn has resulted in a 
significantly decreased introduction of Salmonella Enteritidis in the food chain. Similar 
efforts should be made to lower Salmonella prevalence in broiler meat, not only by focusing 
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on the later stages of production (transport to slaughterhouse, slaughter) which have been 
proven of major importance [14], but also by controlling Salmonella prevalence in broiler 
flocks. 
 
Poultry can become infected with Salmonella through both vertical and horizontal 
transmission of the bacterium [15]. Vertical transmission from the parent to the day-old 
chicken has often been reported, and both Salmonella Enteritidis and Typhimurium can be 
transmitted in this manner. Controlling this transmission route has been the main factor in 
several eradication programs [16-18]. Nevertheless, horizontal transmission in hatcheries 
and farms is often of greater importance, and serovars other than Enteritidis and 
Typhimurium only spread in this way. Risk factors for horizontal transmission include 
inadequate cleaning and disinfection of broiler rearing houses leading to contamination of 
the next flock upon introduction in the rearing house [19-23], a poor level of hygiene in 
general [24], and contamination of the feed [25-27]. Other risk factors for horizontal 
transmission are the size of the farm [27, 28], the season in which the chickens are reared 
[28], the presence of insects and rodents on the farm [29], and contamination of Salmonella 
negative flocks during transport to the slaughterhouse due to contaminated crates and 
contamination in the slaughterhouse [30-32]. Chickens are thus usually infected by oral 
uptake of Salmonella bacteria from the environment (oral-fecal route) and the infection will 
spread rapidly through bird to bird contact [33]. Chickens can, however, also become 
infected with Salmonella after inhaling even low numbers of the bacteria, and thus is the 
respiratory route an additional portal of entry for Salmonella [34, 35]. 
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1.5.2 Salmonella pathogenesis 
 
1.5.2.1 Initial colonization of the host 
 
Chickens primarily become infected with Salmonella after oral ingestion of the bacterium. 
Once ingested, the bacterium needs to pass through the alimentary system and survive the 
acidic environment of the stomach. It is able to do so because of the so-called acid-tolerance 
response, a complex adaptive system which allows the bacteria to synthesize a large number 
of acid shock proteins, including the RpoS σ-factor, Ada and Fur, which ensure bacterial 
survival in acidic environments [36, 37]. The Salmonella bacteria that survive the acidic 
environment of the stomach proceed through the gastrointestinal tract (GIT), the primary 
site of attachment for Salmonella in the chicken. Here, epithelial and immune cells lining the 
GIT are the initial protective barrier against Salmonella. Additionally, Salmonella has to 
compete with the gut microbiota to make contact with enterocytes in order to colonize the 
GIT. 
 
1.5.2.2 Invasion and epithelial inflammation 
 
Once contact has been made with the intestinal enterocytes, Salmonella adheres to the 
epithelial cells lining the GIT, a process facilitated by flagellae and fimbriae present on the 
bacterial cell wall [38, 39]. When attached to the intestinal epithelium, Salmonella expresses 
a type three secretion system (T3SS), a multiprotein effector complex which facilitates 
uptake and invasion in epithelial cells [40, 41]. This “molecular needle” is encoded on 
Salmonella Pathogenicity Island 1 (SPI-1), a genomic region which contains virulence genes 
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involved in Salmonella adhesion, invasion and toxicity. The structure consists of more than 
20 proteins, forms a structure spanning both the inner and outer membrane of the bacterial 
cell wall and ending in a needle-like structure that extends outward from the bacterial cell 
surface (Figure 4). 
 
 
Figure 4: Structural overview of the Type Three Secretion System (adapted from [42]). 
 
The main function of the T3SS is to inject effector proteins in the intestinal epithelial cells to 
which Salmonella is attached. The effector proteins injected in epithelial cells by the T3SS are 
often also encoded on the SPI-1, and include proteins like Sip (Salmonella invasion proteins), 
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Sop (Salmonella outer proteins) and several others [43]. These proteins have different 
functions, and can contribute to Salmonella pathogenicity in various ways. For instance, 
SopB, one of the proteins translocated through the T3SS, activates secretory pathways in the 
epithelial cells, facilitating inflammation and disturbing the ion balance within the cell [44-
46]. This results in an increased secretion of fluids in the GIT and consequently diarrhea, 
which contributes to the further spread of the Salmonella bacterium [43]. Other effector 
proteins, such as SopA and SopE2 also play a role in Salmonella gastroenteritis [45]. SopE2 
does this by reprogramming host gene expression through the transcriptional factor NF-κB, 
which results in the induction of pro-inflammatory cytokines such as IL-8 and TNF-α, eliciting 
mucosal inflammation [47]. Other factors than those associated with SPI-1 contribute to the 
gastroenteritis associated with Salmonella infection as well. The Salmonella genome 
encodes several molecules that are also present in other bacteria, like lipopolysaccharides 
(LPS), flagella and curli fimbriae, which are recognized by the host as pathogen-associated 
molecular patterns (PAMP’s). These PAMP’s interact with Toll-like receptors (TLR’s) and are 
thus capable of stimulating the pro-inflammatory pathways of the immune system, inducing 
IL-8 production and neutrophil influx [48-50]. For instance, flagellin, the monomer which 
forms the filaments in the bacterial flagellum, interacts with TLR5, hereby activating NF- κB 
and IL-8 secretion [51]. The developed pro-inflammatory response eventually leads to 
epithelial damage, allowing essential nutrients to become available for the Salmonella 
bacteria [51]. Overactivation of these pathways will however disturb host cell homeostasis in 
various ways, which might affect the ability of Salmonella to survive, replicate and 
disseminate in the host [51]. To avoid this, Salmonella has developed mechanisms to 
downregulate the pro-inflammatory response by delivering antagonic and thus anti-
inflammatory effectors (like SptP and SpvC) into the host cell. One of these anti-
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inflammatory effectors, SptP, which is encoded on SPI-1, disrupts the actin cytoskeleton and 
thus antagonizes the cytoskeleton rearrangements induced by SopE [52, 53], limiting 
Salmonella invasion and thus reducing the severity of the inflammatory response. 
 
Invasion of Salmonella in GIT epithelial cells is a complex process, induced by effector 
proteins injected through the T3SS which interact with the actin cytoskeleton of the 
epithelial cell (Figure 5). Injection of SopE, SopE2 and SopB effector proteins activates the 
RhoGTPases Rac, Cdc42 and RhoG, which results in actin cytoskeleton remodeling via cellular 
proteins [54, 55]. SipA and SipC induce rearrangements in the cytoskeleton by binding 
directly to actin, localizing actin polymerization at the bacterial entry site [54, 55]. SipC is 
able to nucleate filamentous actin (F-actin) and promote F-actin bundling [54]. SipA 
stimulates these SipC activities and can stabilize F-actin by directly antagonizing the action of 
depolymerizing factors in the cell, thus inhibiting actin depolymerisation at early stages of 
infection [54, 56]. These interactions with the host cell machinery cause the host cell 
membrane to extend outwards and to form filopodia [51], a process known as membrane 
ruffling which facilitates engulfment of Salmonella by the host cell membrane through 
pinocytosis. Another T3SS effector protein, SopD, is able to directly promote this process 
due to its role in membrane fission and macropinosome formation, and increases 
inflammation and fluid secretion as well [57]. After the bacteria are taken up through 
pinocytosis, they becomes internalized in a vesicle known as the Salmonella containing 
vacuole (SCV) [58].  
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Figure 5: The role of different Salmonella Pathogenicity Island 1 (SPI-1) effector proteins in Salmonella 
invasion (adapted from [59]). After adhesion to the epithelial cell, Salmonella injects several effector proteins 
in the host cell through a Type Three Secretion System (T3SS). One of these effector proteins, SipA, binds 
directly to actin and indirectly to the actin-bundling protein T-plastin. This results in localized actin 
polymerization at the bacterial entry site and the formation of filopodia, facilitating cellular entry for 
Salmonella. SipC, another effector protein, induces actin bundling as well and contributes to the formation of 
filopodia. The SopE effector proteins binds and activates host cell proteins Rac and Cdc42, which results in the 
formation of membrane ruffles and facilitates entry of Salmonella in the host cell as well. SptP, on the other 
hand, binds and inactivates Rac and Cdc42, antagonizing the effects of SopE and limiting the host pro-
inflammatory response.  
 
Recent research has however suggested that Salmonella is able to invade host cells in ways 
independent of SPI-1 T3SS [54, 60, 61]. It is known that the association of Salmonella Outer 
Membrane Proteins (OMP) with host cells triggers a variety of biological events, like the 
induction of innate and adaptive immune responses [62]. However, it has been shown that 
the Salmonella OMP Rck and PagN are able to induce cell invasion through an alternate 
mechanism, which is suggested to play a role in systemic infection as well [54, 60, 63]. This 
so-called “Zipper” mechanism allows Salmonella to enter the host cell in a receptor-
mediated way, by tightly binding the bacteria to the host cell membrane and initiating only 
minor cytoskeletal rearrangements through contact between bacterial ligands and host cell 
surface receptors (Figure 6) [54, 61]. 
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Figure 6: Different strategies used by Salmonella for invasion and proliferation in eukaryotic cells (adapted 
from [61]). Salmonella is able to invade host cells through a Trigger mechanism or a Zipper mechanism. The 
Trigger mechanism is mediated by the T3SS and induces major cytoskeletal rearrangements. Following entry, 
Salmonella is taken up in the SCV, which undergoes different stages of maturation while Salmonella replicates 
inside. This replication is associated with the formation of SIF’s, which facilitate delivery of nutrients to the SCV. 
A portion of the bacteria are able to escape the SCV and multiply in the cytosol of the epithelial cell. The Zipper 
mechanism, mediated by Rck, induces minor cytoskeletal rearrangements and leads to internalization of the 
bacteria into a vacuole [61]. 
 
In either way, internalization in the SCV plays a key role in Salmonella survival and 
proliferation in intestinal epithelial cells and macrophages, as the SCV is the only cellular 
compartment in which Salmonella cells survive and replicate [51, 64]. This SCV is a 
membrane-bound compartment initially integrated in the early endocytic pathway (Figure 
7). In order for Salmonella to avoid destruction by phagolysosomal pathways in the cell and 
survive here, the delivery of host lysosomal enzymes to the SCV needs to be circumvented 
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[51, 65, 66]. To do so, the Salmonella bacterium expresses a second T3SS encoded on 
Salmonella Pathogenicity Island 2 (SPI-2) once it becomes incorporated in the SCV, which 
allows for the delivery of a wide variety of effector proteins in the SCV. One of these effector 
proteins, SsaB, inhibits intracellular trafficking by blocking the fusion of the SCV with the 
lysosomes, and thus allows Salmonella to avoid destruction by phagolysosomal pathways 
[67, 68]. Other SPI-2 T3SS effectors seem to mediate generally later steps in SCV biogenesis, 
including movement of the SCV to the juxtanuclear region and the subsequent maintenance 
of this position, formation of an actin meshwork around the SCV and anterograde extension 
of Salmonella induced filaments (SIF) along microtubules [66]. The formation of an F-actin 
network around the SCV is termed vacuole-associated actin polymerization (VAP), a process 
which allows the SCV to migrate to a perinuclear position in the host cell close to the Golgi 
apparatus, presumably to facilitate interception of transport vesicles containing nutrients 
and membrane fragments, essential for bacterial replication within the SCV [51, 69]. This 
movement is mediated by two SPI-2 T3SS effectors, SseF and SseG, which supposedly recruit 
the motor protein dynein to the SCV via a Rab7-RILP interaction [70, 71]. In addition, it has 
been observed that intracellular Salmonella can induce the formation of lysosomal SIF’s 
through the expression of the SifA effector protein [72]. Although the role of these long 
filamentous membrane structures is not completely clear, they facilitate fusion of the SCV 
with other vesicles in the cell, and are suggested to play a role in Salmonella replication [40]. 
The SifA protein has another role also, as it contributes to maintaining the membrane 
integrity of the SCV, together with PipB2, SseJ and SopD2 SPI-2 T3SS effector proteins [73]. 
Other SPI-2 T3SS effectors are involved in ubiquitin modification, immune signaling and 
target the host cytoskeleton [66, 73], and contribute to the survival and replication of 
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Salmonella in the SCV. Salmonella is thus able to survive and replicate in epithelial cells and 
even spread to underlying tissues, resulting in a systemic infection. 
 
 
 
Figure 7: The Salmonella containing vacuole (SCV) and the role of different Salmonella Pathogenicity Island 2 
(SPI-2) effector proteins during Salmonella’s intracellular phase (adapted from [74]). After internalization in 
the epithelial cell, Salmonella becomes enclosed in a phagosome that fuses with lysosomes, acidifies and 
shrinks to become the Salmonella containing vacuole (SCV). The SPI-2 Type Three Secretion System (T3SS) is 
induced within the SCV and translocates different effector proteins (yellow spheres) across the SCV membrane. 
SPI-2 effector proteins such as SifA and PipB2 contribute to the formation of Salmonella-induced filaments (Sif) 
along microtubules (green) and regulate the accumulation of microtubule-motor proteins (yellow stars) on the 
Sif and the SCV. Another effector protein, SseJ, is active on the phagosome membrane and contributes to 
maintaining membrane integrity of the SCV. Effector proteins SseF and SseG direct Golgi-derived vesicle traffic 
toward the SCV, presumably to provide nutrients and membrane fragments to the SCV. Other SPI-2 T3SS 
effector proteins, such as SspH2, SpvB and SseI are believed to play a role in the actin accumulation around the 
SCV. 
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1.5.2.3 Survival in macrophages and dendritic cells 
 
Salmonella is able to develop invasive and systemic infections [43]. When this is the case, a 
fraction of the SCV’s transcytose to the basolateral membrane of the epithelial cells, where 
the Salmonella bacteria are engulfed by phagocytes (neutrophils, inflammatory monocytes 
which differentiate into macrophages or dendritic cells) which interact with these invading 
bacteria [51]. In addition, dendritic cells have also been reported to directly take up bacteria 
from the intestinal lumen by opening the tight junctions and sending dendrites to the lumen 
[75]. It has been shown that Salmonella is able to replicate within macrophages [76, 77], 
while they do not appear to replicate within dendritic cells even though they remain viable 
[64]. After engulfment by these phagocytes, the Salmonella bacterium is once again 
internalized in a SCV, triggering events similar to those when internalized in epithelial cells 
that allow survival and replication within the infected cells. Migration of these infected 
phagocytes leads to systemic dissemination of the bacteria to several other tissues, such as 
the liver and spleen, where Salmonella preferentially replicates [78]. When this is the case, 
Salmonella is rapidly distributed in lymphoid and non-lymphoid tissues and eventually 
transported to different internal organs, resulting in life-threatening septicemia. 
 
1.5.2.4 Regulation of Salmonella pathogenicity 
 
Salmonella Pathogenicity Island 1 (SPI-1), is a genomic region which contains virulence genes 
involved in Salmonella adhesion, invasion and toxicity. Expression of these SPI-1 genes is 
however tightly regulated by both environmental conditions and a variety of regulatory 
genes [79, 80]. The main regulatory gene for SPI-1 is HilA, which is necessary for controlling 
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expression of the invasive phenotype and is essential for colonization of the chicken caecum 
[81]. HilA activates other SPI-1 genes, like invF, by interacting with their promoters [79, 80, 
82]. Transcription of HilA itself is governed by several other regulatory proteins, like HilC and 
HilD (also encoded on SPI-1) and Lon, Fis, FliZ, Hha and Png (encoded outside the SPI-1) [80]. 
Transcription of HilC and HilD is in turn governed by regulatory cascades, in which the two 
component regulators BarA/SirA and PhoP/Q, and the Csr post-translational control system 
play an important role [79]. Several proteins which are part of these regulatory cascades are 
able to sense environmental changes, resulting in a system in which SPI-1 genes are only 
expressed under the right conditions, namely when invading host cells. Optimal expression 
of SPI-1 occurs under conditions present in the gut lumen, like low oxygen, high osmolarity, 
at neutral to slightly basic pH and during exponential growth phase [80, 83]. Additionally, the 
short chain fatty acid acetate stimulates the expression of SPI-1 genes, while propionate and 
butyrate repress the expression [84]. This is because Salmonella has adapted in a way that 
the genes involved in invasion are only expressed when necessary, that is, when present in 
the GIT of a susceptible host. 
 
Salmonella Pathogenicity Island 2 (SPI-2), on the other hand, is a genomic region containing 
virulence genes involved in intracellular Salmonella survival and replication. The ssrA gene 
plays an important role in this process, as the corresponding protein is an essential 
component of the SsrAB regulatory system for the SPI-2 [85]. Therefore, the ssrA gene is 
crucial for survival of Salmonella in host cells [86]. Expression of ssrA itself is modulated by 
global regulatory proteins [87] such as PhoPQ [88], OmpR/EnzV [89-91] and SlyA [92, 93]. 
Additionally, nucleoid associated proteins (NAP’s) like IHF and Fis and remarkably, HilD also 
have a role in SPI-2 transcription regulation [85, 94, 95]. Similarly to regulation of SPI-1, the 
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regulatory proteins form part of a cascade which allows Salmonella to sense its environment 
and allows expression of SPI-2 genes when residing in the SCV. SPI-2 gene expression is 
induced by low concentrations of Ca2+, Mg2+, phosphate starvation and a decrease in 
osmolarity [85, 89, 96]. SPI-2 is also expressed under low pH and repressed under alkaline 
pH conditions [85, 89, 97]. At the same time, expression of SPI-2 is repressed when SPI-1 is 
upregulated and vice versa, a mechanism in which HilD plays a central role [94, 95]. This 
complex regulation for both SPI-1 and SPI-2 allows for a carefully regulated temporal and 
spatial expression of Salmonella virulence genes, which is essential for Salmonella enterica 
pathogenesis [85]. 
 
1.6 Salmonella control in broilers 
 
Poultry meat is consumed in large quantities worldwide and because its consumption can be 
linked to foodborne Salmonella outbreaks, efforts have been made to reduce Salmonella 
contamination in broiler meat and poultry products in general. These efforts often focus on 
the whole broiler meat production chain and form part of a ‘farm-to-fork’ strategy [98]. 
Safety measures can be taken at different levels, namely pre-harvest (i.e. on-farm), on the 
harvest level (i.e. during transport to the slaughterhouse and at the slaughter line) and post-
harvest (i.e. during processing and during preparation). It is however most probable that 
concurrent control measures applied at every level of the broiler production chain will lead 
to the largest reduction in poultry meat contamination with Salmonella. 
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1.6.1 Biosecurity measures 
 
Biosecurity is defined as a collection of rules and procedures that minimize exposure of a 
susceptible population to an infectious (biological) agent [99, 100]. In practice, this 
comprises a wide range of hygienic and management measures, taken on different levels of 
the production chain. An important measure is the exclusion of enteropathogens such as 
Salmonella at the top of the production chain by testing and culling infected flocks, which 
would otherwise result a widespread dissemination of Salmonella from the purelines to their 
progeny through vertical transmission [15, 100]. This remains also important for the lower 
stages in the broiler production chain, as vertical transmission of Salmonella Enteritidis and 
Typhimurium from a parent flock to day-old chickens leaving the hatchery has often been 
reported as well [14, 17, 18]. In addition, eggs generate large amounts of dust and airborne 
fluff during the hatching process which, in the case of contaminated eggs, can contribute to 
the spread of Salmonella to other eggs and hatched chicks [100-102]. To avoid this, 
numerous methods are employed to disinfect eggs, such as disinfection with ultraviolet light, 
ozone or chemicals [100, 103, 104]. Consequently, reducing the vertical transmission of 
Salmonella has been a main controlling factor in many eradication programs. 
 
In addition to vertical transmission, horizontal transmission of Salmonella in hatcheries and 
on the farm during the rearing period is of major importance for the spread of Salmonella. It 
is known that inadequate cleaning and disinfection of the broiler rearing houses can lead to 
contamination of the following flock [14]. Therefore, broiler rearing houses should be 
cleaned and disinfected thoroughly between production cycles. Introduction of possible 
carriers such as birds, rodents and insects in the farm house should obviously be avoided 
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[105]. To do so, housing must be designed in a way that it prevents entry of any carrier, and 
incorporate pest-control measures such as traps and baits [100]. In addition, not only pests 
can be responsible for the introduction of Salmonella, but also humans can be a source of 
enteric pathogens [106]. Human access to the rearing house is however necessary, and 
sanitation and hygiene measures such as hygiene gates should thus be employed [100]. 
 
Another critical point in control of Salmonella in poultry production is the poultry feed, as 
this has frequently been found to be a major vehicle of transmission of Salmonella [100, 
107]. While feed components are typically heat-treated to avoid this, the feed often 
becomes contaminated during processing [107, 108]. This can however be overcome by 
thermal processing or chemical treatment of the complete feed [109]. Similarly, drinking 
water provided to the chickens should be free of enteropathogens and of potable quality. In 
practice, on-farm water is frequently drawn from natural sources and should be treated with 
chemicals or filtered before being presented to the animals [100]. Additionally, the drinking 
systems used in broiler production are often susceptible to biofilm formation, which makes 
sanitation and regular cleaning essential [100]. 
 
Movement of the animals should be done on all-in-all-out basis, even on farms with different 
flocks and houses, as multi-age stocking increases the risk of the infection spreading from 
one flock to another. All-in-all-out movement thus minimizes the likelihood of cross-
contamination between flocks [100, 110]. Transport of poultry from the farm to the 
slaughterhouse can result in their exposure to Salmonella through the use of contaminated 
dirty crates, trucks and catching or pickup crews, resulting in contamination and subsequent 
cross-contamination [100]. Transport can also contribute to the horizontal spreading of 
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Salmonella from farm to farm, and should be managed through washing of truck tires and 
transport crates [14]. 
 
During processing in the slaughterhouse, there are several critical points that can impact the 
contamination rate of the broiler carcasses by Salmonella. A first critical point is scalding 
[100]. During this process the carcasses pass through a tank filled with hot water, which 
opens the follicles of the skin and facilitates removal of the feathers. However, when the 
water in the tank is stagnant, temperature of the water is too low and there are excessive 
excreta in the tank, pathogens are able to proliferate and spread to all carcasses entering the 
tank [100]. Time spent by the carcass in the tank, temperature and pH of the tank and the 
use of antimicrobial chemicals (which is not allowed in Europe) thus need to be adjusted in a 
way that enteric pathogen prevalence is minimized [100]. Another critical point is head 
pulling and evisceration, as removal of the head and viscera can lead to carcass 
contamination with Salmonella via crop leakage and intestinal rupture [100, 111]. Hygienic 
measures, such as frequent washing of hands and the use of automated systems with high 
pressure sprays that minimize contact between soil or viscera and carcass can help reduce 
cross-contamination during this process [100]. Chilling, the process in which the carcass 
temperature is reduced, can be exploited to reduce carcass pathogen load, by cooling the 
carcasses in a chlorinated liquid. This is however prohibited in the European Union where, 
due to consumer demand for more chemical free products, air-chilling is used as the final 
chilling stage [100]. Finally, rapid freezing of the chicken carcasses (which is most frequently 
applied in the USA) may offer additional control for enteric pathogens [100]. 
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1.6.2 Feed and drinking water: composition and supplementations 
 
It is clear that, in order to avoid the introduction of Salmonella on the farm, poultry feed and 
drinking water should be Salmonella-free. However, the poultry feed can also play a more 
prominent role in Salmonella control, as several features of the feed can influence 
Salmonella colonization. It has been shown that the feed structure affects susceptibility of 
poultry to Salmonella infection [112] and that the cereal type used in broiler feed can affect 
Salmonella colonization, probably due to changes in intestinal health of the birds [113]. Feed 
particle size and feed form also have an effect on Salmonella colonization, with pelleted feed 
resulting in higher caecal Salmonella concentrations than a mashed diet [114]. In addition, it 
has been shown that fermented feed can also reduce caecal Salmonella colonization [115]. 
Similarly, protein content and protein source may help to protect the intestine from 
pathogen colonization [112]. Plant-protein based feeds often contain various non-starch 
polysaccharides that are fermented in the caecum to organic acids, which are 
disadvantageous to pathogens and thus lower their colonization [112]. Adding exogenous 
enzymes to the feed can improve the nutritional value of the feed and alter the microbial 
population of the GIT indirectly, reducing pathogen load [112]. For instance, by adding 
endoxylanase and alpha-amylase to a corn-based diet, it is possible to lower Salmonella 
prevalence and reduce caecal colonization [112]. As such, poultry feed can have an effect on 
Salmonella infections and play a role in control programs. 
 
Adding certain supplements to feed and drinking water can also help lower Salmonella 
colonization and shedding. Obvious examples of such additives are antibiotics, but as these 
antimicrobials are no longer allowed as animal growth promoters and their usage should be 
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avoided due to microbial resistance, alternatives have been investigated and developed. 
One type of such alternatives are organic acids, whose addition to feed or drinking water can 
decrease Salmonella colonization and possibly other pathogenic bacteria [116]. These 
compounds comprise short chain fatty acids (SCFA) (such as acetic acid, propionic acid, 
butyrate), medium chain fatty acids (MCFA) (contain 6 to 12 carbons, such as caproic, 
caprylic, capric and lauric acids) and other organic acids, with SCFA’s and MCFA’s being 
mostly used as additives in poultry feed. Originally, organic acids were added to the feed in 
order to decontaminate it, but later it was shown that this could also help reduce Salmonella 
colonization and invasion of chicken tissues [116]. In high concentrations (> 1%), such as in 
the drinking water or in the crop after ingestion, these acids exert bacteriostatic or 
bactericidal effects against Gram-negative bacteria by entering the cell in undissociated form 
[112, 116]. Once inside the bacterial cell, the acid dissociates and as a result the intracellular 
pH decreases, disrupting cellular processes and delaying growth [112, 116]. In the case of 
Salmonella, low concentrations of organic acids can also negatively influence epithelial 
invasion by interacting with genes that play a role in invasion. It has been shown that 
butyrate and propionate decrease hilA, invF and sipC expression, while butyrate also 
downregulates hilD and as a consequence, SPI-1 expression [84, 116, 117]. SCFA’s can thus 
regulate the invasive phenotype of Salmonella. MCFA’s have also been shown to decrease 
Salmonella invasion in intestinal epithelial cells [118]. Organic acids have however more 
pronounced antimicrobial effects in the upper part of the GIT because they are absorbed 
before they can reach the lower GIT [98]. As Salmonella mainly colonizes the lower GIT 
[119], coating or micro-encapsulating organic acids might prevent early absorption and allow 
organic acids to be released further down the GIT, where Salmonella resides [98, 116]. 
Overall, SCFA’s and MCFA’s can thus be used to reduce Salmonella colonization and invasion 
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in broilers by adding them to the feed or drinking water, which can help to reduce infection 
pressure on the farm [112]. 
 
Other important feed and drinking water additives are probiotics and prebiotics. By 
administering probiotics to poultry, it is possible to induce changes in the chicken intestinal 
community structure [120], and this can be done by adding probiotics to the feed or drinking 
water. Administration of probiotics can also stimulate the immune system, elicit crosstalk 
with other beneficial bacteria and induce the production of host enzymes, which in turn may 
lead to a beneficial nutritional and growth-promoting effect [112, 121, 122]. Other potential 
mechanisms allowing probiotic cultures to exclude enteric pathogens such as Salmonella 
include competition for receptor sites, competition for nutrients and the production of 
antimicrobial metabolites (such as bacteriocins, fatty acids and hydrogen peroxide) [98, 112, 
121]. Microorganisms used as probiotics in animal feed are mainly strains belonging to the 
genera Lactobacillus, Enterococcus, Pediococcus and Bacillus, while yeasts such as 
Saccharomyces also have been used [112, 123]. It has been shown that certain probiotic 
strains are able to reduce Salmonella colonization [122, 124-126], although the observed 
effects are often of minor magnitude [98]. 
 
Prebiotics are non-digestible feed ingredients that beneficially affect the host by selectively 
stimulating the growth and/or activity of one or more bacterial species already present in 
the GIT of the host [98, 127]. Prebiotics are oligo- and polysaccharides such as lactose, 
lactulose, fructo-oligosaccharides (FOS), galacto-oligosaccharides (GOS) and 
arabinoxylooligosaccharides (AXOS), which confer beneficial effects on poultry health by 
indirect means, as the fermentable prebiotics provide a substrate for metabolism and 
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growth of the normal intestinal microbiota [98, 112, 128]. They thus inhibit pathogen 
colonization by competitive exclusion (see below) and may stimulate production of 
antibacterial metabolites such as lactic acid, fatty acids or bacteriocins [112]. It is also 
possible that prebiotics (such as mannanoligosaccharides) can bind to pathogens in the 
intestinal lumen, and therefore block adhesion of these pathogens to epithelial cells [112, 
129]. However, studies on the ability of prebiotics to control colonization by 
enteropathogens such as Salmonella have produced inconsistent results [112, 130]. Lactose 
for instance, was shown to reduce Salmonella organ invasion when added to the feed [131], 
but when administered through the drinking water, it failed to reduce Salmonella 
colonization in crop and caecum [132]. Therefore, to achieve more unambiguous results, it 
might be more advisable to simply directly administer beneficial micro-organisms to poultry. 
 
Newly hatched chicks have little opportunity to develop a normal intestinal flora due to the 
clean housing conditions in which they are reared [98, 112, 133]. This absence of a natural 
microbiota makes young chickens highly vulnerable for enteric pathogen infection, and has 
been linked with a pronounced susceptibility for Salmonella infections [98, 112, 134]. It is 
however possible to administer an alimentary tract suspension derived from adult birds to 
young ones, which confers them an adult-type microflora and decreases their susceptibility 
not only for Salmonella, but for enteric pathogen infection in general [135-137]. This is called 
competitive exclusion (CE), and several hypothetical mechanisms have been proposed to 
explain the efficacy of CE products. One is that the introduced microbiota physically obstruct 
attachment sites lining the intestine, preventing pathogen attachment [109]. Other possible 
mechanisms include modulation of the immune system, competition for essential nutrients 
(limiting pathogen growth) and the production of volatile fatty acids or bacteriocins [109]. 
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The true mode of action of CE products however remains enigmatic. In practice, CE products 
can be added to the drinking water, but uptake of drinking water in the first 24h after 
hatching is variable and viability of anaerobic microbiota can be variable in water [98]. To 
overcome these problems, spray application in the hatchery can be applied [98, 109, 138]. 
The efficacy of these CE products has been clearly documented in both experimental studies 
and in the field [98, 137], and it has been shown that treatment with a CE product can 
reduce Salmonella prevalence in flocks. A drawback of these CE cultures is that they are 
undefined mixtures containing a wide array of micro-organisms and thus may contain 
pathogenic microorganisms [98]. However, this problem can be overcome by thoroughly 
testing the CE culture for the presence of pathogens. Attempts to use simpler defined CE 
mixtures, which would not comprise a pathogen risk, have however been less successful 
[109]. 
 
Another possible alternative to combat Salmonella is bacteriophage therapy. Bacteriophages 
are natural predators of their bacterial hosts and can cause lysis of bacterial cells as part of 
their life cycle. Indeed, it has been shown that certain bacteriophages are able to reduce 
carriage of Salmonella in live birds [139, 140]. At the moment, a bacteriophage-containing 
product (SALMONELEX®, Micreos) which can be used to reduce Salmonella contamination 
during food processing has been “generally recognized as safe” (GRAS) by American 
authorities and is commercially available, but the consequences of its use in the poultry 
industry remains to be investigated. 
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1.6.3 Vaccination 
 
Vaccination can be an effective means to protect poultry against Salmonella and it is 
generally accepted that cell-mediated immunity plays a more important role in the 
protection against Salmonella than humoral responses after vaccination [133]. In accordance 
with this, it has been observed that CD8+ T-cells play an important role in the immunological 
defense after primary infection in young chicks [141] and that clearance of Salmonella 
Typhimurium infections in chickens correlates with high cell-mediated responses [142, 143]. 
In addition, intraperitoneal administration of recombinant IFN-gamma decreases Salmonella 
colonization, underlining the importance of cell-mediated immune mechanisms in the 
systematic clearance of Salmonella [144]. Also, experimental infection of chickens with a 
Salmonella Enteritidis field strain causes heterophilic granulocytes to accumulate in the 
propria mucosae of the caeca, which is accompanied by expression of CXC chemokines and 
polumorphonuclear cell (heterophil, PMN) influx [145]. It has been shown that heterophils 
up-regulate mRNA expression of pro-inflammatory chemokines IL-6 and Il-8 and the 
inflammatory cytokine TGF-b4 in response to Salmonella Enteritidis, while expression of Il-18 
and IFN-γ is down-regulated [146]. Finally, heterophil-depleted chickens are much more 
susceptible to Salmonella Enteritidis [147, 148], further illustrating the importance of cell-
mediated immunity in Salmonella infections in poultry. On the other hand, it has been 
observed that B-cell-depleted chickens have increased faecal excretion and higher caecal 
Salmonella counts, indicating that humoral immune responses might also play a role in 
intestinal Salmonella colonization [149].  
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By vaccinating chickens it is possible to stimulate the immune system and induce an immune 
response against Salmonella which decreases the amount of Salmonella colonizing the 
animal [150, 151]. It has been used successfully against host-specific Salmonella serotypes 
(e.g. Salmonella Gallinarum) that cause severe systemic disease in poultry [152] and to 
reduce Salmonella Enteritidis prevalence in layer flocks and consequently the number of 
Salmonella contaminated eggs [153-155]. However, vaccinating to protect broilers against 
Salmonella is different from layers, as the life span of broiler chickens is only 5-6 weeks while 
the production period for laying hens is much longer [150]. Because the immune system is 
not yet fully developed the first weeks post-hatch, immunization in the first weeks of the life 
of the broiler chicken is not very effective [156-158]. This is however the period that 
chickens are most vulnerable for infection, and infection with Salmonella during this period 
in which the chick is highly susceptible often results in persistent infections [159-161]. 
Despite this, vaccination is sometimes used in broilers. The Salmonella vaccines used in 
practice for poultry are divided in two categories: live-attenuated and inactivated vaccines 
[150]. 
 
Live attenuated vaccines are Salmonella strains containing mutations or deletions in genes 
that are essential for metabolism, virulence or survival in the host [133, 150]. They have 
several advantages over inactivated vaccines, as they stimulate both cell-mediated and 
humoral immune responses and usually express all appropriate antigens in vivo [133, 162]. 
Moreover, they can easily be administered orally [150, 151]. A major disadvantage is that 
they might persist in the chickens as well as in the environment, possibly resulting in the 
introduction of the vaccine in the food chain and posing a threat to human health [163, 164]. 
On the other hand, such a persistence can be desirable, as horizontal spread of the live 
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vaccine would result in the protection of birds that were not originally immunized [150]. 
Other disadvantages of live vaccines are possible interference with Salmonella testing 
procedures and the possibility of reversion to virulence [165, 166]. This reversion to 
virulence has already been observed in the field [167], yet can be avoided by using vaccine 
strains in which the genetic alteration is introduced by deleting the target genes instead of 
mutating these. Several challenges are associated with administering live vaccines and 
vaccines in general to poultry, like the high costs of vaccine administration, a too late 
induction of immunity and difficulties with delivering the vaccine in a uniform way to the 
poultry flock [150]. However, because live vaccines can easily be administered orally, 
different methods to administer these on a large scale have been developed. Application 
through the drinking water or by spray are most widely used for Salmonella vaccines, 
allowing for a relatively uniform, early and cheap administration. 
 
Killed vaccines are whole bacteria that are inactivated by heat, formalin, acetone or other 
treatments [150]. A major advantage of these vaccines is the absence of a living organism 
that can spread and persist in the environment and can potentially cause a health risk [150]. 
Killed vaccines are also able to elicit strong antibody responses, yet do not stimulate a cell 
mediated response like live vaccines do [150] (while cell-mediated immunity is more 
important than humoral responses in protection against Salmonella). In addition, these killed 
vaccines can express only a limited number of antigens (those present at harvest), while live 
vaccines usually express all relevant antigens [151, 152]. Consequently, killed vaccines often 
need an adjuvant to improve the sub-optimal immune response they elicit [150]. Another 
drawback is that they may provide rather limited cross-protection against salmonellae of 
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antigenically unrelated serotypes [151]. Despite this, killed vaccines are more widely 
employed as they raise fewer customer concerns [100]. 
 
Other vaccines, such as subunit vaccines and vector vaccines are also being used in poultry 
practice, but not to combat Salmonella. However, it is believed that the next generation of 
poultry vaccines will primarily be subunit vaccines delivering antigens from possibly multiple 
pathogens in viral or DNA vectors [168]. 
 
1.6.4 Colonization-inhibition 
 
Immunization with live vaccines represents an important method to increase resistance of 
chickens against Salmonella infection [169]. However, in addition to the development of an 
adaptive immune response, oral administration of a live attenuated Salmonella strain to day-
old chicks can confer protection against Salmonella infection within hours after 
administration [169]. This phenomenon is called colonization-inhibition (CI) and can be 
exploited to protect young chickens against Salmonella infection. Chickens are most 
vulnerable for infection shortly after hatching, and infection with Salmonella during this 
period in which the chick is highly susceptible often results in persistent infection [159-161]. 
As other treatments such as feed additives, drinking water supplementation or classical 
vaccination do not offer protection that early in the life of the broiler chick, CI may represent 
a powerful tool to protect broilers against Salmonella infection early after hatching. 
 
The potential of CI was discovered in the 1980’s, during a study to identify bacteria 
possessing colonization-inhibition activity against Salmonella [170]. In this study, one group 
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of chicks was found to be completely protected against infection by Salmonella Typhimurium 
after they were infected with a Salmonella Montevideo strain picked up from contaminated 
feed shortly after hatching. When isolating the Salmonella Montevideo strain from the feed 
and administering it to newly hatched chickens, they were again able to establish a profound 
protection when the animals were challenged with a Salmonella Typhimurium strain 24 h 
later. Further studies confirmed these early observations and showed that live bacteria were 
necessary for CI to take place, as killed preparations were not able to confer protection to 
the chicks [171]. In addition, it was shown that only organisms from within the Salmonella 
genus were able to inhibit Salmonella colonization, while other Enterobacteriaceae were not 
able to do so [171, 172]. Further research showed that the observed CI effect was induced 
quickly (6 h) after administration of the first strain and could still be observed when the 
chickens were challenged 7 days after administration of the first strain [173]. This CI effect 
could also be observed in ducks and gnotobiotic pigs, suggesting that CI is not restricted to 
chickens [174, 175]. In addition, the genus-specific CI effect becomes less pronounced as the 
normal intestinal microbiota develops further [176]. Other research concerning CI showed 
that not all Salmonella strains are equally inhibitory and that no strain is fully protective 
against all Salmonella strains [169]. The colonization inhibition effect also appears to be 
serovar-specific [158, 177], meaning that a better protection is established when inhibitory 
strain and challenge strain belong to the same serotype [173, 176]. The most profound 
inhibition is however observed between isogenic strains [169, 176]. These observations led 
to the belief that oral administration of live Salmonella vaccines could thus allow for an early 
protection of young chickens by CI, followed by the development of a long-lasting immunity 
when the birds reach immunological maturity [133, 178]. 
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Salmonella strains that are to be used as CI strains need to be attenuated in a way that they 
are no longer virulent, and should thus no longer be shed or carried by the chicken at 
slaughter [133]. Additionally, it is preferable that a CI strain is altered in a way that it is 
distinguishable from wild-type strains, so that it does not interfere with detection of wild-
type strains in testing procedures and control programs [165]. A CI strain should confer 
protection quickly after administration and this protection should last until slaughter age 
[133]. Preferably this CI strain would also confer protection against a broad range of 
Salmonella serotypes, but since protection is stronger when CI strain and challenge strain 
are more closely related, this might be a difficult criterion to achieve. Finally, like live 
vaccines, CI strains can possibly revert to virulence [166, 167]. This risk can however be 
avoided by using CI strains in which the genetic alteration is introduced by deleting the 
target gene instead of mutating it. Such strains are however genetically modified organisms 
(GMO’s) and thus have to comply to the high standard of safety defined for this class of 
organisms. A lot of effort has already been put in developing CI strains. Most of these 
developed strains had mutations in genes involved in energy metabolism, anabolic pathways 
or virulence. Examples are aroA, phoP, ompC, lon, cpxR or the genes coding for adenylate 
cyclase, a cAMP receptor and DNA adenine methylase [179-188]. In addition to these strains, 
several commercially available live vaccine strains have been developed which could possibly 
induce a CI effect as well [150]. 
 
Earlier research has shown that a Salmonella Enteritidis ΔhilA strain is a strain that is 
significantly reduced in its ability to colonize orally infected one day old chicks [81]. More 
importantly, when this strain was used as a CI strain and administered to day old chickens, it 
conferred a pronounced protection against Salmonella Enteritidis infection by lowering 
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faecal shedding and caecal and internal organ colonization [189, 190]. The Salmonella 
Enteritidis ΔhilA strain was however still present at slaughter age in low amounts, and could 
thus not be used as a CI strain in practice. Therefore, it was proposed to introduce additional 
mutations in this strain to further attenuate it and obtain a putative Salmonella Enteritidis CI 
strain that is cleared by slaughter age. Additional research had already revealed that a 
Salmonella Enteritidis ΔssrA strain maintains its invasiveness, yet is impaired in intracellular 
survival and thus colonizes internal organs to a much more limited extent [86]. When 
administering this strain as a CI strain to one day old chicks, it offered protection against 
experimental Salmonella Enteritidis challenge, but was also still present at slaughter age. 
Introducing both the hilA and ssrA mutations might however result in a sufficiently 
attenuated strain that is cleared by slaughter age and maintains the protective effect 
conferred by the single mutants. 
 
A major drawback for vaccination with live vaccines is that vaccinated animals can no longer 
be distinguished from field-exposed animals by serological tests, as the immunized animals 
produce antibodies against both the vaccine strain and the wild-type strain [165]. Earlier 
research has however shown that non-flagellated live vaccines (due to deletion of a gene 
crucial for flagellin structure or assembly) are not able to induce an anti-flagellin immune 
response after administration, which allows easy serological differentiation between 
vaccinated and infected animals that do produce a detectable anti-flagellin immune 
response [165]. Introducing an additional mutation in a flagellin gene would thus also allow 
for serological differentiation between animals treated with the CI strain and animals that 
are actually infected with Salmonella. In addition, such a mutation would render the strain 
immotile, which allows for easy bacteriological differentiation between wild-type and 
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attenuated strains and ensures that the CI strain does not interfere with Salmonella 
monitoring programs (which often comprise a motility test). 
 
It is currently thus unknown whether deletion of the hilA, ssrA and fliG gene in a Salmonella 
Enteritidis and Salmonella Typhimurium strain will result in CI strains that are safe for use in 
broilers and are able to protect broilers against Salmonella Enteritidis and Typhimurium 
colonization from the moment of hatch until slaughter. Additionally, it is not known how CI 
strains should be administered to broilers in practice. 
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2 Aims 
 
Despite the implementation of different control measures, up to 3.4 % of Belgian broiler 
flocks and 4.9 % of the broiler meat available in retail were contaminated with Salmonella in 
2012. Therefore, consumption of contaminated poultry meat remains an important cause of 
food-borne Salmonella infections in humans. Young chickens often become infected with 
Salmonella early in life, as they are highly susceptible to Salmonella infections due to the 
absence of a natural microflora and an underdeveloped immune system. Therefore, there is 
a need for control methods that protect broilers from day-of-hatch until slaughter age 
against infection with Salmonella. Colonization-inhibition, a concept in which a live 
Salmonella strain is orally administered to day-old chickens and protects against subsequent 
challenge, can potentially be used as a novel control method to achieve this goal. 
 
The aim of this thesis was the development of a CI strain that is safe for use in broilers and is 
able to protect them early after hatching against Salmonella infection. This means that this 
CI strain should no longer be virulent, cannot revert to virulence, should be cleared by 
slaughter age and does not interfere with testing procedures. In addition, this strain should 
be able to offer protection against Samonella early in the broiler life and this protection 
should last until slaughter age. Finally, this CI strain or a combination of CI strains belonging 
to different serovars should offer protection against a broad range of Salmonella serovars. 
 
In a first study, we investigate whether a Salmonella Enteritidis hilAssrAfliG deletion strain 
can be used as a CI strain to protect broilers against Salmonella Enteritidis. This was done by 
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investigating whether this CI strain is safe and whether this strain offers protection against 
experimental Salmonella Enteritidis challenge. 
 
In a second study, we investigate whether a Salmonella Typhimurium deletion hilAssrAfliG 
mutant strain is safe for use in broilers and whether this strain is able to protect them 
against Salmonella Typhimurium infection early after hatching. In addition, we studied 
whether the Salmonella Enteritidis hilAssrAfliG deletion mutant strain and the Salmonella 
Typhimurium hilAssrAfliG deletion strain can be applied simultaneously to protect broilers 
early after hatching against both Salmonella Enteritidis and Salmonella Typhimurium 
infection. 
 
In a third study, a practical application method which allows for early and uniform 
application of the Salmonella Enteritidis hilAssrAfliG strain was investigated. To do so, two 
application methods frequently used in practice, drinking water and spray application, were 
compared. 
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Abstract 
 
Consumption of contaminated poultry meat is an important cause of Salmonella infections 
in humans. Therefore, there is a need for control methods that protect broilers from day-of-
hatch until slaughter age against infection with Salmonella. Colonization-inhibition, a 
concept in which a live Salmonella strain is orally administered to day-old chickens and 
protects against subsequent challenge, can potentially be used as control method. In this 
study, the safety and efficacy of a Salmonella Enteritidis ΔhilAssrAfliG strain as a 
colonization-inhibition strain for protection of broilers against Salmonella Enteritidis was 
evaluated. After administration of the Salmonella Enteritidis ΔhilAssrAfliG strain to day-old 
chickens, this strain could not be isolated from the gut, internal organs or faeces after 21 
days of age. In addition, administration of this strain to one-day-old broiler chickens 
decreased faecal shedding and caecal and internal organ colonization of a Salmonella 
Enteritidis challenge strain administered one day later using a seeder bird model. To our 
knowledge, this is the first report of an attenuated Salmonella strain for which both the 
safety and efficacy has been shown in long-term experiments (until slaughter age) in 
broilers. Consequently, the Salmonella Enteritidis hilAssrAfliG strain can potentially be used 
as a live colonization-inhibition strain for controlling Salmonella Enteritidis infections in 
broilers. 
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Introduction 
 
Despite the implementation of numerous monitoring and control measures in broiler 
production, Salmonella is still an important cause of poultry meat associated human 
infections [5]. Broilers can be infected with Salmonella at any time during the production 
period or even post-harvest. In the first days after hatching however, chicks are highly 
susceptible to Salmonella infections arising from environmental contamination [159]. 
Contact in this period, even with very low numbers of Salmonella, may result in persistent 
infections [160, 161]. Following early infection, broilers may thus still be colonised by the 
time they reach slaughter age, resulting in introduction of Salmonella in the slaughterhouse 
and contamination of broiler meat [14]. 
Because young chickens are immunologically immature, classical vaccination as a means to 
protect the animals is not an option [133]. Due to the short production cycle, there is little 
time to develop a protective immune response. Oral administration of a live Salmonella 
culture at day-of-hatch, however, can induce rapid protection of newly hatched chickens 
against a subsequent challenge. This phenomenon is called colonisation-inhibition (CI) [171, 
173, 189-191]. Live attenuated Salmonella strains may be used as CI strains provided that 
they do not colonise the animal persistently and have been cleared at slaughter age. The 
construction of attenuated Salmonella strains by introducing mutations in genes that are 
essential for virulence, while maintaining properties essential for colonisation-inhibition and 
immunogenicity has been proposed as a possible approach for producing CI-strains [133]. As 
demonstrated earlier, Salmonella Enteritidis mutants with a deleted hilA gene, the regulator 
of the Salmonella Pathogenicity Island 1 (SPI-1), inhibit caecal colonisation of challenge 
strains [189, 190]. However, the hilA deletion mutant is insufficiently attenuated [189] and 
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thus additional deletions in virulence genes needed to be added. A candidate gene is ssrA, 
the key regulator of the SPI-2 virulence genes [86]. Mutations that ensure easy serological 
differentiation between animals that are colonised by either wild-type strains or attenuated 
CI strains are also of interest. Therefore, a mutation in the flagellar rotor protein gene fliG is 
a candidate as this ensures loss of flagellar assembly, and thus the inability to induce anti-
flagellin antibodies [192].  
In the current study, a Salmonella Enteritidis ΔhilAssrAfliG strain was evaluated as a potential 
safe and protective colonisation-inhibiting strain. To evaluate safety, faecal shedding, caecal 
and internal organ colonisation of the ΔhilAssrAfliG strain was analysed following oral 
inoculation of day-old chicks. Additionally, we evaluated the efficacy of the ΔhilAssrAfliG 
strain in decreasing colonisation after challenge with a virulent strain, using a seeder bird 
infection model. 
 
Material & methods 
 
Chickens 
One-day-old Ross broiler chickens were obtained from a local hatchery and housed in 
isolation. Experimental groups were housed in separate rooms in containers on wood 
shavings. Commercial feed and drinking water were provided ad libitum. Experiments were 
performed with the permission of the Ethical Committee of the Faculty of Veterinary 
Medicine, Ghent University, Belgium. 
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Bacterial strains and Salmonella Enteritidis deletion mutants 
Salmonella Enteritidis 76Sa88 NalR is a well-characterized strain originally isolated on a 
poultry farm [159, 193] and was used for the production of isogenic mutants. Deletion of 
hilA, ssrA and fliG genes was done using the one-step inactivation method described by 
Datsenko and Wanner [81, 194]. By transducing the mutant srrA allele into a Salmonella 
Enteritidis 76Sa88 NalR ΔhilA background the ΔhilAssrA double mutant was constructed. 
Similarly, the ΔhilAssrAfliG triple mutant was constructed by transducing the mutant fliG 
allele into a Salmonella Enteritidis 76Sa88 NalR ΔhilAssrA background. 
Salmonella Enteritidis 147 StrepR, originally isolated from egg white, was used as challenge 
strain. This strain is known to colonise the gut and internal organs of chickens to a high level 
[189, 195, 196]. 
 
Experimental design 
Analysis of the colonisation pattern of Salmonella Enteritidis ΔhilAssrAfliG: evaluation of 
safety. Three hundred and sixty one-day-old chicks were divided into 6 groups of 60 and 
each housed in a container of 1 m2. Each group was given 108 CFU of the parent strain or one 
of the mutant strains (ΔhilA, ΔssrA, ΔfliG, ΔhilAssrA or ΔhilAssrAfliG) by oral gavage in the 
crop on the first day of life (day 1). To evaluate colonisation by the wild-type strain and the 
mutant strains, their numbers in caecum and spleen were determined for 10 animals at days 
2, 14, 21, 28, 35 and 42. Shedding of Salmonella was evaluated during the experiment by 
bacteriological analysis of cloacal swabs taken on days 1, 2, 7, 14, 21, 28, 35 and 42.  
 
Evaluation of the colonisation inhibiting potential of Salmonella Enteritidis ΔhilAssrAfliG. 
For this experiment, 2 groups of 75 one-day-old chicks were each housed in a container of 2 
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m². One group was given 108 CFU of the ΔhilAssrAfliG triple mutant strain (CI group) by oral 
gavage in the crop while the other group was given sterile PBS (control group) on day 1. 
Twenty-four hours later, 15 randomly selected chicks in each group were given 105 CFU 
Salmonella Enteritidis 147 StrepR (seeder birds) and housed together with the non-infected 
chicks. To evaluate the colonisation inhibiting potential of the triple mutant strain, bacterial 
counts of both the mutant strain and the challenge strain in caecum and spleen were 
determined on days 7, 21 and 42 for 25 chickens (of which 5 were seeder birds at each time 
point). Shedding of the challenge strain and the triple mutant was followed by cloacal 
swabbing on days 2, 3, 9, 16, 23, 30 and 37. 
 
Bacteriological analysis 
Cloacal swabs were directly inoculated on Brilliant Green Agar (BGA, Oxoid, Basingstoke, 
England) (experiment 1) or Xylose Lysine Deoxycholate agar (XLD, Oxoid, Basingstoke, 
England) (experiment 2) plates with 20 µg/ml nalidixic acid (for the detection of Salmonella 
Enteritidis 76Sa88 NalR strain and the isogenic mutants derived from this strain) or 100 
µg/ml streptomycin (for the detection of Salmonella Enteritidis 147 StrepR). Samples 
negative after direct inoculation were pre-enriched in buffered peptone water (BPW, Oxoid, 
Basingstoke, England) and incubated overnight at 37 °C. One ml of this BPW suspension was 
further enriched by adding 9 ml tetrathionate-brilliant green broth. After overnight 
incubation at 37 °C, a loopful of this suspension was plated on BGA or XLD plates 
supplemented with the appropriate antibiotic. 
Samples of caecum and spleen were homogenized in BPW and 10-fold dilutions were made 
in Hank’s Balanced Salt Solution (HBSS, Invitrogen, Paisley, England). Six droplets of 20 µl of 
each dilution were plated on BGA or XLD supplemented with 20 µg/ml nalidixic acid 
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(experiments 1 and 2) and on plates with 100 µg/ml streptomycin (experiment 2). After 
overnight incubation at 37 °C, the number of CFU/g tissue was determined by counting the 
number of bacterial colonies for the appropriate dilution, dividing this number by 6, and 
multiplying this again by 50 times 10 and the dilution factor, as shown in the following 
formula: CFU/g tissue =  
CFU
6
∗ 50 ∗ 10 ∗ dilution factor 
 Negative samples were enriched as described above. 
 
Statistical analysis 
GraphPad Prism 5 software was used for statistical analysis. A Fisher’s exact test (one-sided) 
was used to analyse mortality rates within differently treated groups. A Kruskal-Wallis test 
(one-way ANOVA, with Dunn’s multiple comparison test) was used to determine statistical 
differences in the number of Salmonella positive cloaca swabs and the number of Salmonella 
positive (after enrichment) spleen and caecum samples, between groups. For statistical 
analysis of numbers of CFU Salmonella per g spleen and caeca, bacterial counts were 
converted into logarithmic form. Samples of caecum and spleen negative after direct plating 
were rated as log10= 0. A two way ANOVA (with Bonferroni correction) was used to 
determine statistical differences in organ colonisation between the group inoculated with 
the Salmonella Enteritidis 76Sa88 NalR strain and those inoculated with a CI strain 
(experiment 1). For the second experiment, the mean CFU/g tissue was calculated for each 
group at every time point and differences between groups were analysed using a Mann-
Whitney test. Differences with p-values lower than 0.05 were considered to be significant. 
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Results 
 
Colonisation pattern of Salmonella Enteritidis ΔhilAssrAfliG: evaluation of safety. Mortality 
in the group inoculated with the wild-type strain (6 out of 60) was significantly higher (p = 
0.0137) as compared to the groups inoculated with any of the deletion mutants (1/60 for 
groups inoculated with ΔhilA, ΔsrrA and ΔhilAssrA strains and zero in groups inoculated with 
ΔfliG and ΔhilAssrAfliG strains). 
 
As shown in Table 1, nearly all cloacal swabs taken 1 day after inoculation were positive, 
except those taken from chickens inoculated with the ΔhilA, ΔhilAssrA (about 90% positive) 
and ΔhilAssrAfliG strain (75% positive). In general, shedding of the wild-type strain and all 
mutant strains gradually declined during the experiment, but the decline was faster for the 
mutant strains. Starting from day 28, none of the animals was shedding the mutant strains, 
except for the ΔfliG mutant. Statistical differences are shown in Table 1. 
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Table 1: The number of cloacal swabs positive for Salmonella Enteritidis 76Sa88 wild-type strain or its hilA, 
ssrA, fliG, hilAssrA and hilAssrAfliG deletion mutants at direct plating and after enrichment, after inoculation 
with one of these strains at day of hatch. 
Strain 
Days 
2 7 14 21 28 35 42 
Wild type 58/60
a
 (59
b
) 48/49 (48) 40/46 (45) 29/36 (33) 16/28 (25) 2/17 (5) 0/8 (0) 
ΔhilA 53/60 (54) 14*/49 (35) 12*/49 (29) 0*/39 (5*) 0*/29 (0*) 0/19 (0) 0/9 (0) 
ΔssrA 59/60 (59) 40/50 (50) 14*/50 (37) 2*/39 (11*) 0*/29 (0*) 0/19 (0) 0/9 (0) 
ΔfliG 59/60 (59) 48/50 (49) 28/50 (48) 12*/40 (22) 2/30 (4*) 3/20 (9) 0/10 (0) 
ΔhilAssrA 53/60 (53) 37/50 (50) 19*/49 (41) 5*/39 (12*) 0*/29 (0*) 0/19 (0) 0/9 (0) 
ΔhilAssrAfliG 45/60 (45) 37/50 (48) 3*/50 (5*) 0*/40 (0*) 0*/30 (0*) 0/20 (0) 0/10 (0) 
a
 Number of positive samples after direct plating/total number of samples 
b
 Number of positive samples after enrichment 
* Significant difference in positive samples in comparison to the 76Sa88 wild type strain (p-value < 0,05) 
 
Bacteriological analysis showed that inoculation with the wild-type strain or the mutant 
strains resulted in a high level of caecal colonisation on the first day after inoculation for all 
strains (ca. 108 CFU/g caecum) (Fig. 1A). Generally, the wild-type strain colonised the caeca 
to higher levels at many time points as compared to the mutants. Bacteriological analysis of 
the spleen showed that the mutant strains colonised the spleen less extensively as 
compared to the wild-type strain, already from the first day post-administration (Fig. 1B). 
Generally, the wild-type strain was present in the highest numbers as compared to the 
mutant strains (102-103 CFU/g until day 21), with still half the samples positive after 
enrichment at day 42. Details and statistical differences are mentioned in the legend of 
Figure 1. The number of caeca and spleen samples positive after enrichment for the 
Salmonella Enteritidis wild-type strain or its deletion mutants are shown in Table 2. 
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Figure 1: Average caecal (A) and spleen (B) colonization of the Salmonella Enteritidis 76Sa88 Nal
R
 wild-type 
strain ( ), its hilA deletion mutant ( ), srrA deletion mutant ( ), fliG deletion mutant ( ), hilAssrA 
deletion mutant ( ) or hilAssrAfliG deletion mutant ( ) after inoculation of chickens on day of hatch 
with 10
8
 CFU of one of these strains. Represented values are log10 CFU/g sample. Samples were taken on day 
2, 14, 21, 28, 35 and 42. The error bars represent the standard error of the means (SEM). Statistical significant 
differences in caecal colonization between the Salmonella Enteritidis 76Sa88 Nal
R
 strain and the CI strains were 
observed on day 14,21 28 and 35 for the ΔhilA strain, day 21, 28 and 35 for the ΔssrA strain, day 21 and 28 for 
the ΔfliG strain, day 21, 28 and 35 for the ΔhilAssrA strain and day 14, 21, 28 and 35 for the ΔhilAssrAfliG strain. 
Statistical significant differences in spleen colonization between the Salmonella Enteritidis 76Sa88 Nal
R
 strain 
and the CI strains were observed on day 2, 14 and 21 for the ΔhilA strain, day 2, 14 and 21 for the ΔssrA strain, 
day 2, 14 and 21 for the ΔfliG strain, 2, 14 and 21 for the ΔhilAssrA strain and day 14 and 21 for the 
ΔhilAssrAfliG strain. 
  
(A) (B) 
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Table 2. The number of caeca or spleen samples positive after enrichment for Salmonella Enteritidis 76Sa88 
wild-type strain or its hilA, ssrA, fliG, hilAssrA and hilAssrAfliG deletion mutants after inoculation with one of 
these strains at day of hatch. 
Groups 
Days 
2 14 21 28 35 42 
Caecum 
Wild type 10
a
/10
b
 9/9 8/8 10/10 9/9 1/8 
ΔhilA 10/10 8/10 3/10 0*/10 1/10 0/9 
ΔssrA 10/10 10/10 10/10 4/10 0*/10 0/9 
ΔfliG 10/10 10/10 7/10 4/10 9/10 1/10 
ΔhilAssrA 10/10 10/10 10/10 3/10 0*/10 0/9 
ΔhilAssrAfliG 10/10 2/10 0*/10 0*/10 0*/10 0/10 
Spleen 
Wild type 9/10 9/9 8/8 9/10 5/9 4/8 
ΔhilA 7/10 3/10 0*/10 0*/10 0/10 0/9 
ΔssrA 8/10 6/10 1*/10 0*/10 1/10 0/9 
ΔfliG 10/10 9/10 1*/10 1*/10 0/10 0/10 
ΔhilAssrA 10/10 4/10 3/10 2/10 2/10 0/9 
ΔhilAssrAfliG 10/10 1*/10 0*/10 0*/10 0/10 0/10 
a
 Number of positive samples after enrichment 
b
 Total number of samples 
* Significant difference in positive samples in comparison to the 76Sa88 wild type strain (p-value < 0,05) 
 
Evaluation of the colonisation inhibiting potential of Salmonella Enteritidis ΔhilAssrAfliG. 
Because the ΔhilAssrAfliG triple mutant strain was cleared after 21 days and was thus 
regarded as safe, this strain was tested for its colonisation inhibition potential. During the 
experiment, 6 chickens out of 75 died in the group inoculated with the Salmonella Enteritidis 
147 challenge strain only (control group), while in the group inoculated with both the 
Salmonella Enteritidis ΔhilAssrAfliG colonisation-inhibition strain and the challenge strain (CI 
group) only 2 chickens out of 75 died. Birds in the control group had severe diarrhoea with 
pasting of the vent, reduced appetite and showed lethargy with drooping of head and wings, 
in contrast to the birds in the CI group. 
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As shown in Table 3, shedding of the ΔhilAssrAfliG strain in the CI group declined rapidly 
after inoculation. Shedding of the challenge strain was higher in the control group as 
compared to the CI group throughout the entire experiment. The number of swabs positive 
for the challenge strain after direct plating remained low in the CI group throughout the 
entire experiment. Furthermore, the number of swabs positive for the challenge strain after 
enrichment was lower for the CI group during the whole experiment. Statistical differences 
are shown in Table 3. 
  
Table 3. The number of cloacal swabs positive for the Salmonella Enteritidis 76Sa88 hilAssrAfliG deletion 
mutant and the Salmonella Enteritidis challenge strain SE147. 
Strains 
Days 
2 3 9 16 23 30 37 
ΔhilAssrAfliG 
mutant 
Control  0/75
a
 (0
b
) 0/75 (0) 0/49 (0) 0/46 (0) 0/22 (0) 0/22 (0) 0/22 (0) 
CI group 12/75 (70) 6/75 (25) 0/50 (0) 0/48 (0) 0/24 (0) 0/24 (0) 0/24 (0) 
SE147 
Control  N/A 11/75 (21) 18*/47 (39) 18*/46 (39) 3/22 (11) 4/22 (8) 2/22 (7) 
CI group N/A 4/75 (13) 5*/50 (33) 2*/48 (25) 1/24 (4) 0/24 (1) 1/24 (2) 
The number of cloacal swabs positive for the Salmonella Enteritidis 76Sa88 hilAssrAfliG deletion mutant after 
inoculation with PBS (Control group) or 10
8
 CFU of the Salmonella Enteritidis ΔhilAssrAfliG strain (CI group) at 
day of hatch is shown in the first 2 rows. The third and fourth row show the number of cloacal swabs positive 
for the Salmonella Enteritidis challenge strain SE147 after inoculation with 10
5
 CFU (both groups) on day 2 of 
the experiment. 
a
 Number of positive samples after direct plating/total number of samples 
b
 Number of positive samples after enrichment 
* Significant difference in positive samples between control and CI group (p-value < 0,05) 
 
Bacteriological analysis shows that by day 7, the ΔhilAssrAfliG strain was no longer present in 
the caecum of any of the chickens, not even after enrichment (data not shown). In the group 
treated with the CI strain, bacterial loads of the challenge strain in the caecum were 
significantly lower than in the control group throughout the entire study (p<0.0001 on day 7, 
p=0.0003 on day 21 and p=0.0069 on day 42) (Figure 2). Analysis of the spleen samples 
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showed that the ΔhilAssrAfliG strain was no longer present on day 7, not even after 
enrichment (data not shown). The difference in spleen colonisation by the challenge strain 
between both groups was significant (p=0.0035) on day 7, but not on day 21 (Figure 2). The 
challenge strain could only be detected after enrichment on day 42 (data not shown). 
 
 
Figure 2. Caecal (A, B, C) and spleen (D, E, F) colonization of the Salmonella Enteritidis challenge strain SE147. 
Animals were orally challenged at day 2 with 10
5
 CFU, either (CI group) or not (control group) after 
administration of 10
8
 CFU of a Salmonella Enteritidis ΔhilAssrAfliG deletion mutant strain. Subfigures A and D 
represent colonization on day 7, B and E on day 21 and C and F on day 42. Represented values are log10 of 
CFU/g sample. The middle horizontal line represents the mean, the error bars represent the standard error of 
mean (SEM). The number of chickens equals 25, 22 and 22 in the control group and 25, 24 and 24 in the CI 
group on day 7, 21 and 42 respectively. The number of samples negative after direct plating (n) and the 
number of samples negative after direct plating but positive after enrichment (z) are displayed below the group 
name. 
(A) 
(B) 
(C) 
(D) 
(E) 
(F) 
n=2, 
z=2 
n=11, 
z=11 
n=2, 
z=2 
n=16, 
z=16 
n=11, 
z=11 
n=21, 
z=19 
n=14, 
z=12 
n=23, 
z=4 
n=12, 
z=6 
n=24, 
z=11 
n=22, 
z=5 
n=14, 
z=12 
Chapter 3.1  Experimental Study 1 
67 
Discussion 
 
Newly hatched chicks are highly susceptible to Salmonella infections during the first days of 
life and inoculation with very low doses can result in persistent infections [159-161]. This can 
be explained by the absence of a normal gut microbiota [197, 198] and immaturity of the 
immune system of young chickens [156, 157, 199]. Because the immune system of young 
chickens is still immature, classical vaccination is not an effective means to achieve 
protection against Salmonella infection during the first days of life [133]. However, 
administration of a live Salmonella vaccine can induce a rapid colonisation-inhibiting effect 
that protects the bird against subsequent challenge with another Salmonella strain. 
 
Colonisation-inhibition is induced by orally administering live Salmonella organisms that 
subsequently protect against challenge with another Salmonella strain belonging to the 
same serotype [158, 173, 200]. By administering the live Salmonella strain at day-of-hatch, it 
is possible to achieve protection against Salmonella very early in life [133]. A lot of effort has 
been put in developing strains that are appropriate for use as CI strains [170, 171]. In 
addition to being protective against Salmonella infection, it is essential that the CI strains do 
not induce clinical signs, have no adverse effects on performance and are cleared from the 
host at slaughter age to avoid transmission to the food chain. In practice, colonisation of the 
host and shedding should be zero at even earlier ages, i.e. the age at which sampling is 
performed in national or international monitoring schemes. The ΔhilAssrAfliG mutant strain 
used in the current study did not induce clinical symptoms and was cleared at 21 days of age 
in the first experiment and at 7 days of age in the second experiment, showing a very good 
safety profile. This observed difference in clearance could be due to the difference in 
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experimental design (stocking density) between both experiments, or due to a different 
intestinal microflora acquired by the chicks prior to inoculation. In any way, this rapid 
clearance is in contrast with several other tested colonisation-inhibiting strains, including 
Salmonella Enteritidis hilA, ssrA and sipA deletion mutant strains, as these are not cleared by 
3 weeks of age or even slaughter age, which would interfere with implemented Salmonella 
monitoring measures or even result in introduction of Salmonella in the slaughterhouse 
[189, 190, 201]. A Salmonella Typhimurium ΔrpoS deletion mutant displayed an unaffected 
potential to inhibit caecal colonisation of a challenge strain but was still fully virulent to 
chickens and thus cannot be used as a CI strain in practice [183]. Several other colonisation-
inhibiting strains, including ompC, lon, cpxR, rfc, rfaH and crp deletion mutants have been 
used only in short-term studies [182-184]. It is thus unknown whether they would interfere 
with implemented monitoring measures. 
 
An efficacious live vaccine for broilers is a strain that induces a high degree of protection 
against intestinal colonisation and shedding, and a high degree of protection against 
systemic infection. The ΔhilAssrAfliG mutant strain inhibited caecal and spleen colonisation 
and shedding of a virulent Salmonella Enteritidis strain throughout the production period. 
Because the young chickens are immunologically immature and the virulent strain is rapidly 
cleared from the chicken caecum and internal organs, it is unlikely that an immune response 
against Salmonella is responsible for this early effect. Because the CI strain has to fulfil 
certain criteria concerning safety, of which rapid clearance is one, and it is unlikely that an 
immune response against Salmonella has been elicited before the CI strain is cleared from 
the host, it is possible that the protection offered by the CI strain will disappear along with 
the strain as it is cleared from the host. However, by this time point, the chickens are much 
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less susceptible to Salmonella infection due to maturation of the immune system and 
acquisition of gut microbiota. 
 
The risk of Salmonella infection is very high the first days after introduction of the chicks on 
the farm due to environmental contamination [133]. To obtain protection induced by 
colonisation-inhibition as early as possible, the colonisation-inhibiting strain should be 
administered as soon as possible after hatching, to minimize the period in which the chicks 
are not protected. In practice, this could be done by spraying a solution containing the 
Salmonella Enteritidis ΔhilAssrAfliG strain on the newly hatched chicks in the hatchery. 
Therefore, the colonisation-inhibiting strain would need to be able to survive on the 
newborn chick’s body. Other methods used for controlling Salmonella in poultry, such as 
acidification of the drinking water or the use of feed additives, do not offer similar 
protection levels compared to CI strains soon after hatching, mostly because the young birds 
have a delay in consumption of feed and water after introduction in a poultry house. The use 
of organic acids, essential oils, pro- and prebiotics as feed supplement can be an effective 
control measure used to protect broiler chickens against caecal colonisation and faecal 
shedding by Salmonella but the protective responses elicited by these compounds only start 
several days post-hatch [116, 202, 203]. Therefore, administration of CI strains that protect 
chicks early post-hatch might be a valuable addition to these strategies. 
 
Broiler chickens can be colonised by several Salmonella serotypes other than Salmonella 
Enteritidis. Earlier observations suggest that the colonisation-inhibiting effect is stronger if 
the CI strain and the challenge strain belong to the same serovar [169]. Generally, a higher 
degree of protection is observed if the CI strain and the challenge strain are more closely 
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related [133]. It is therefore highly probable that the Salmonella Enteritidis ΔhilAssrAfliG 
mutant strain does not offer a high degree of protection against serotypes other than 
Salmonella Enteritidis. It is however possible to generate deletion mutants similar to the 
ΔhilAssrAfliG mutant strain for other serovars, which would allow to quickly and efficiently 
respond to Salmonella serovars that are emerging or are of greater importance for broilers. 
In 2012, only 0.2 % of all broiler flocks in the European Union were positive for Salmonella 
Enteritidis while 2.9 % were positive for other serovars [5]. It is therefore important to 
develop a means of protection against not only Salmonella Enteritidis, but other Salmonella 
serovars as well. Because colonisation-inhibition is limited between serovars, it is 
theoretically possible to administer a mixture of Salmonella strains belonging to different 
serovars that do not inhibit each other but do inhibit virulent wild-type strains. This has 
already been shown for a mixture of wild-type Salmonella strains and similar levels of 
protection should be obtainable using CI stains [169]. Ideally, Salmonella vaccines should 
have markers enabling the differentiation from Salmonella wild-type strains. As the 
ΔhilAssrAfliG mutant strain is non-motile, it is distinguishable from wild-type strains by 
bacteriological means. Additionally, it has been shown that different flagellin deficient 
strains do not generate anti-flagellin antibodies in laying hens, allowing serological detection 
of anti-flagellin antibodies to discriminate between a vaccinated and infected flock [165, 
188]. However, because the strain is rapidly eliminated from the host and its reduced ability 
to colonize systemic sites, it is unlikely that the ΔhilAssrAfliG mutant strain induces an 
immune response in broilers that would permit differentiation between a vaccinated and 
infected flock. 
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In conclusion, a significant reduction in faecal shedding and caecal and internal organ 
colonisation by a virulent Salmonella Enteritidis challenge strain could be obtained by 
administering a Salmonella Enteritidis ΔhilAssrAfliG mutant strain to one day old broiler 
chickens. Consequently, this strain can potentially be used as a live colonisation-inhibition 
strain for controlling Salmonella Enteritidis in broilers. 
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Abstract 
 
Consumption of contaminated poultry meat is still an important cause of Salmonella 
infections in humans and there is a need for control methods that protect broilers from day-
of-hatch until slaughter age against infection with Salmonella. Colonisation-inhibition, a 
concept in which a live Salmonella strain is orally administered to day-old chickens and 
protects against subsequent challenge, can potentially be used as control method. In this 
study, the efficacy of a Salmonella Typhimurium ΔhilAssrAfliG strain as a colonisation-
inhibition strain for protection of broilers against Salmonella Typhimurium was evaluated. 
Administration of a Salmonella Typhimurium ΔhilAssrAfliG strain to day-old broiler chickens 
decreased faecal shedding and strongly reduced caecal and internal organ colonisation of a 
Salmonella Typhimurium challenge strain administered one day later using a seeder bird 
model. In addition, it was verified whether a colonisation-inhibition culture could be 
developed that protects against both Salmonella Enteritidis and Typhimurium. Therefore, 
the Salmonella Typhimurium ΔhilAssrAfliG strain was orally administered simultaneously 
with a Salmonella Enteritidis ΔhilAssrAfliG strain to day-old broiler chickens, which resulted 
in a decreased caecal and internal organ colonisation for both a Salmonella Enteritidis and a 
Salmonella Typhimurium challenge strain short after hatching, using a seeder bird model. 
The combined culture was not protective against Salmonella Paratyphi B varietas Java 
challenge, indicating serotype-specific protection mechanisms. The data suggest that 
colonisation-inhibition can potentially be used as a versatile control method to protect 
poultry against several Salmonella serotypes. 
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Introduction 
 
Despite the implementation of monitoring and control measures in broiler production, 
Salmonella is still an important cause of poultry meat associated human infections [5]. 
Broilers often become infected with Salmonella early after hatching as they are highly 
susceptible to infection during these first days of life [159]. This is mainly due to the absence 
of normal gut microbiota in young chickens and the immaturity of their immune system 
[156, 157, 197-199]. Infection during this period, even with low numbers of Salmonella, can 
lead to persistent carriers [160, 161]. These broilers are often still infected at slaughter age, 
which may result in introduction of Salmonella in the slaughterhouse and food chain [14]. 
Consequently, prevention of infection in this period in which the chick is highly susceptible 
to infection could strongly reduce the introduction of Salmonella in the food chain. 
Colonisation-inhibition (CI) is a phenomenon in which chickens are administered a live 
Salmonella strain that protects against subsequent challenge with another Salmonella strain 
[170]. By administering a CI strain that colonises the gut rapidly and extensively, it is possible 
to increase resistance to Salmonella strains quickly after hatching [189]. This concept has 
been recognized for a long time, and a great deal of effort has been put in developing strains 
that are appropriate for use as CI strains [133, 171]. Earlier research demonstrated that 
deletion of the hilA, ssrA and fliG genes in a Salmonella Enteritidis strain resulted in a CI 
strain that was safe and effective in protecting broilers against challenge with a Salmonella 
Enteritidis wild-type strain [204]. Because there is greater inhibition within a serovar than 
between serovars [169], the Salmonella Enteritidis ΔhilAssrAfliG strain can be expected to 
mainly protect against Salmonella Enteritidis infection, and not or to a lesser extent against 
e.g. Salmonella Typhimurium infection. In 2012, 0.3 % of all broiler flocks were positive for 
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Salmonella Enteritidis and Salmonella Typhimurium in Europe, while 2.8 % were positive for 
other Salmonella serotypes [5]. Consequently, if CI strains are needed that protect against 
these other serovars, new CI strains need to be developed. It is however unknown whether 
introduction of the hilA, ssrA and fliG mutations in a Salmonella strain belonging to another 
serovar yields a CI strain displaying the same degree of attenuation and similar protective 
properties as the Salmonella Enteritidis ΔhilAssrAfliG strain. Additionally, it is not known 
whether a combination of two or more CI strains, belonging to different serovars, is able to 
protect against infection by different Salmonella serovars. 
In the present study, the efficacy of a Salmonella Typhimurium hilAssrAfliG deletion mutant 
as a CI strain was evaluated. Secondly, the protective effect of a CI culture consisting of both 
a Salmonella Enteritidis and Typhimurium hilAssrAfliG deletion mutant against Salmonella 
Enteritidis, Typhimurium and Paratyphi B var. Java infection was evaluated. 
 
Material & methods 
 
Chickens 
One-day-old Ross 308 broiler chickens were obtained from a local hatchery and housed in 
separate rooms in containers on wood shavings. Commercial feed and drinking water were 
provided ad libitum. Experiments were performed with the permission of the Ethical 
Committee of the Faculty of Veterinary Medicine, Ghent University, Belgium (experiment 
authorisation number: EC2012/96). 
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Bacterial strains and deletion mutants 
A spontaneous nalidixic acid-resistant mutant of Salmonella Typhimurium strain 112910a, 
originally isolated from a pig stool sample [205], was used for the production of isogenic 
mutants. This resistance has previously been shown to have no impact on the in vivo results 
[171]. Deletion of hilA, ssrA and fliG genes in this strain was done using the one-step 
inactivation method described by Datsenko and Wanner [194]. Salmonella Typhimurium 
MB2136, a streptomycin resistant wild-type strain originally isolated from swine was used as 
a challenge strain. A nalidixic acid-resistant Salmonella Enteritidis hilAssrAfliG deletion 
mutant, which has been described earlier [204], was also used in this study. The original 
Salmonella Enteritidis 76Sa88 strain, from which the Salmonella Enteritidis hilAssrAfliG 
deletion mutant is derived, was originally isolated on a poultry farm [159, 193]. Salmonella 
Enteritidis 147 (streptomycin resistant), a strain originally isolated from chicken egg white 
and which is known to colonise the gut and internal organs of chickens to a high level [189, 
195, 196], was used as a challenge strain. Additionally, a wild-type Salmonella Paratyphi B. 
var. Java strain (carbenicillin resistant) originally isolated from poultry, was also used as a 
challenge strain. 
 
Experimental design 
 
Experiment 1: Efficacy of a Salmonella Typhimurium hilAssrAfliG deletion mutant against 
experimental Salmonella Typhimurium infection 
In order to evaluate the persistence of a Salmonella Typhimurium ΔhilAssrAfliG strain in 
chickens and its efficacy against colonisation by a wild type Salmonella Typhimurium strain, 
225 one-day-old chicks were divided into three groups of 75 animals and each group was 
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housed in a container of 2 m². Two groups (Group V and C) were given 109 CFU of the 
Salmonella Typhimurium ΔhilAssrAfliG strain by oral gavage while the third group was given 
sterile HBSS (Hank’s Balanced Salt Solution, Invitrogen, Paisley, England) as a control (Group 
I). Twenty-four hours later, 25 randomly selected chickens in Group I and Group C were 
given 105 CFU Salmonella Typhimurium MB2136 by oral gavage. These seeder birds were 
housed together with the other chickens of their group. Bacterial counts in caecum and 
spleen were determined for one third of the original number of chickens by bacteriological 
analysis at 7, 21 and 42 days old. At each time point, one in three sampled animals were 
seeder birds. Shedding of both strains was monitored by cloacal swabbing on days 2, 3, 9, 
16, 23, 30 and 37. 
 
Experiment 2: Efficacy of simultaneous administration of a Salmonella Typhimurium hilAssrAfliG 
and a Salmonella Enteritidis hilAssrAfliG deletion mutant against infection with several Salmonella 
serotypes 
In order to evaluate the efficacy of a CI culture containing a Salmonella Enteritidis 
ΔhilAssrAfliG and Salmonella Typhimurium ΔhilAssrAfliG strain against infection by several 
Salmonella serotypes, 60 one-day-old chickens were divided into 6 groups of 10 animals. 
Three of these groups (Group VSE, VST and VSJ) were given 0.5 ml of a mixture containing 2 
x 108 CFU/ml of the Salmonella Enteritidis ΔhilAssrAfliG strain and 2 x 108 CFU/ml of the 
Salmonella Typhimurium ΔhilAssrAfliG strain by oral gavage. The three remaining groups 
(CSE, CST and CSJ) were given sterile HBSS as a control. Twenty-four hours later, 2 randomly 
selected chickens in each group were given 105 CFU of a challenge strain by oral gavage. 
These seeder birds were then housed together again with the other chickens of their group. 
Groups VSE and CSE were challenged with Salmonella Enteritidis strain 147, Groups VST and 
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CST with Salmonella Typhimurium strain MB2136 and Groups VSJ and CSJ with the wild-type 
Salmonella Paratyphi B var. Java strain. Bacterial counts of CI strains and challenge strains in 
caecum and spleen were determined by bacteriological analysis on day 7. 
 
Bacteriological analysis 
Cloacal swabs were directly inoculated on Xylose Lysine Deoxycholate agar (XLD, Oxoid, 
Basingstoke, England) plates with 20 µg/ml nalidixic acid (Sigma-Aldrich, St. Louis, MO, USA) 
or 100 µg/ml streptomycin (Sigma-Aldrich, St. Louis, MO, USA). Samples negative after direct 
inoculation were pre-enriched in buffered peptone water (BPW, Oxoid, Basingstoke, 
England) and incubated overnight at 37 °C. One ml of this suspension was further enriched 
by adding 9 ml tetrathionate-brilliant green broth (Merck, Darmstadt, Germany). After 
overnight incubation at 37 °C, this suspension was plated on XLD plates supplemented with 
the appropriate antibiotic. Samples of caecum and spleen were homogenized in BPW and 
10-fold dilutions were made in HBSS. Six droplets of 20 µl of each dilution were plated on 
XLD plates supplemented with 20 µg/ml nalidixic acid, 100 µg/ml streptomycin or 100 µg/ml 
carbenicillin (Sigma-Aldrich, St. Louis, MO, USA). After overnight incubation at 37 °C, the 
number of CFU/g tissue was determined by counting the number of bacterial colonies on the 
plates. 
 
Statistical analysis 
GraphPad Prism 5 software was used for statistical analysis. A Fisher’s exact test (one-sided) 
was used to analyse differences in mortality between groups. A Kruskal-Wallis test (one-way 
ANOVA, with Dunn’s multiple comparison test) was used to determine statistical differences 
of the number of Salmonella positive cloaca swabs among groups. Bacterial counts in 
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caecum and spleen were converted into logarithmic form for statistical analysis. Samples of 
caecum and spleen negative after direct plating were rated as log10= 0. The mean CFU/g 
tissue was calculated for each group on every time point and differences between groups 
were analysed using a Kruskal-Wallis test (one-way ANOVA, with Dunn’s multiple 
comparison test) (experiment 1) or a Mann-Whitney test (experiment 2). Differences with p-
values lower than 0.05 were considered to be significant. 
 
Results  
 
Experiment 1: Efficacy of a Salmonella Typhimurium hilAssrAfliG deletion mutant against 
experimental Salmonella Typhimurium infection 
During the experiment, four chickens died in Group V, five in Group I and four in Group C. 
The observed differences in mortality were not statistically significant. 
 
Shedding of the Salmonella Typhimurium ΔhilAssrAfliG strain remained high during the 
entire experiment in Group V (Table 1). Shedding of this strain decreased quickly in Group C. 
The Salmonella Typhimurium ΔhilAssrAfliG strain was excreted until day 16 by a limited 
number of chickens, after which it could no longer be detected. Shedding of the Salmonella 
Typhimurium challenge strain was lower in the group treated with a Salmonella 
Typhimurium ΔhilAssrAfliG strain during the entire experiment when compared to the sham-
treated control. Statistical differences are shown in Table 1. Data on shedding of the 
Salmonella Typhimurium ΔhilAssrAfliG strain on days 3, 9 and 16 of the experiment are not 
available due to overgrowth of other bacteria on the culture media. 
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Table 1. The number of cloacal swabs positive for a Salmonella Typhimurium ΔhilAssrAfliG strain or a Salmonella Typhimurium challenge strain. Groups V and C were 
orally inoculated with 10
9
 CFU of a Salmonella Typhimurium ΔhilAssrAfliG strain at day 1 of the experiment (day-of-hatch). Groups I and C were challenged with 10
5
 CFU of a 
Salmonella Typhimurium challenge strain on day 2 of the experiment. Samples were taken at days 2, 3, 9, 16, 23, 30 and 37 of the experiment. 
Strain Group Day 2 Day 3 Day 9 Day 16 Day 23 Day 30 Day 37 
Salmonella Typhimurium 
ΔhilAssrAfliG strain 
V 75/75
a
 (75
b
) 75/75 (72*) 49/49 (47) 47/47 (30*) 24/24 (20*) 24*/24 (20*) 22*/23 (18*) 
C 75/75 (67) NA/75 (17*) NA/50 (NA) NA/48 (10*) 0/23 (0*) 0*/22 (0*) 0*/22 (0*) 
Salmonella Typhimurium 
challenge strain 
I NA 18/75 (8) 45*/50 (41*) 35*/49 (12) 5/25 (5) 10/25 (7) 10/25 (7) 
C NA 12/75 (0) 10*/50 (0*) 0*/48 (0) 0/23 (0) 0/22 (0) 0/22 (0) 
a
 Number of positive samples after enrichment/total number of samples 
b
 Number of positive samples after direct plating 
* Significant difference in positive samples between both groups (p-value < 0.05) 
NA = Not available 
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Bacteriological analysis of the caecum samples showed that the Salmonella Typhimurium 
ΔhilAssrAfliG strain colonised the caecum to similar high levels in Group V and Group C on 
day 7 (Figure 1). The bacterial load of this strain was mean log10= 7.48 CFU/g in Group V and 
mean log10= 6.12 CFU/g in Group C. This reduced to mean log10= 6.01 CFU/g on day 21 and 
mean log10= 4.23 CFU/g on day 42 in Group V. The strain could no longer be detected on day 
42 in Group C. No data were available for the caecum of Group C on day 21 due to 
overgrowth of other bacteria on the culture media. In the spleen, the bacterial load of the 
Salmonella Typhimurium ΔhilAssrAfliG strain amounted on day 7 to mean log10= 2.05 CFU/g 
in Group V and log10= 1.61 CFU/g in Group C. Bacterial numbers reduced as the experiment 
proceeded, as the load amounted to mean log10= 0.337 CFU/g in Group V and mean log10= 
0.341 CFU/g in Group C on day 21. This reduced further to mean log10= 0.097 CFU/g in Group 
V on day 42. By then, the Salmonella Typhimurium ΔhilAssrAfliG strain could no longer be 
detected in Group C. 
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Figure 1. Caecal (A, B, C) and spleen (D, E, F) colonisation by a Salmonella Typhimurium hilAssrAfliG deletion 
mutant strain. Chickens in Group V and C were given 10
9
 CFU of a Salmonella Typhimurium ΔhilAssrAfliG 
deletion mutant strain at day-of-hatch. Additionally, chickens in Group C were given 10
5
 CFU of a Salmonella 
Typhimurium challenge strain on day 2 of the experiment. Subfigures A and D show colonization on day 7, B 
and E on day 21 and C and F on day 42. Values shown are log10 of CFU/g sample. The horizontal lines represent 
the mean, the error bars represent the standard error of mean (SEM). The number of samples equals 25, 23 
and 23 in Group V and 25, 23 and 22 in Group C on day 7, 21 and 42 respectively. No data are available for the 
caeca of Group C on day 21. 
 
Bacteriological analysis of the caecum and spleen showed that the Salmonella Typhimurium 
challenge strain colonised the caecum of the chickens in Group I to high levels, while it could 
not be detected in any of the caeca of the chickens in Group C at any time point (Figure 2). 
The bacterial load and number of spleens positive for the Salmonella Typhimurium challenge 
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strain in Group I was initially high, but declined as the experiment proceeded. The 
Salmonella Typhimurium challenge strain could not be detected in any of the spleens on day 
42 in Group I, and in any of the spleens of the chickens belonging to Group C at any time 
point. 
 
 
Figure 2. Caecal (A, B, C) and spleen (D, E, F) colonisation by a Salmonella Typhimurium challenge strain. 
Chickens in Group C were given 10
9
 CFU of a Salmonella Typhimurium hilAssrAfliG deletion mutant strain at 
day-of-hatch. Chickens in Group I and C were given 10
5
 CFU of a Salmonella Typhimurium challenge strain on 
day 2 of the experiment. Subfigures A and D show colonization on day 7, B and E on day 21 and C and F on day 
42. Values shown are log10 of CFU/g sample. The horizontal lines represent the mean, the error bars represent 
A) 
B) 
C) 
D) 
E) 
F) 
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the standard error of mean (SEM). The number of samples equals 25, 24 and 25 in Group I and 25, 23 and 22 in 
Group C on day 7, 21 and 42 respectively. 
 
Experiment 2: Efficacy of simultaneous administration of a Salmonella Typhimurium hilAssrAfliG 
and a Salmonella Enteritidis hilAssrAfliG deletion mutant against infection with several Salmonella 
serotypes 
None of the chickens died during the experiment. Bacteriological analysis of the samples 
showed that the Salmonella Enteritidis and Typhimurium ΔhilAssrAfliG strains colonised the 
caecum and spleen to a similar level in all treated groups. Mean colonisation was log10= 6.87 
± 0.12 and 6.44 ± 0.76 CFU/g in the caeca, and log10= 0.74 ± 0.50 and 2.02 ± 0.77 CFU/g in 
the spleens of Groups VSE and VST, respectively. Data on colonisation by the CI culture in 
Group VSJ is not available because the Salmonella Paratyphi B var. Java strain is, like the CI 
strains, nalidixic acid resistant. Consequently, the CI strains could not be distinguished from 
the challenge strain. Additionally, bacteriological analysis of caecum and spleen showed that 
colonisation by the Salmonella Enteritidis challenge strain was significantly lower in the 
caecum of the group treated with CI culture (Figure 3). No differences could be observed in 
spleen colonisation. Similarly, colonisation by the Salmonella Typhimurium strain was 
significantly lower in the caecum of the treated group, while no significant difference could 
be observed in the spleen. Colonisation by the Salmonella Paratyphi B var. Java strain did not 
differ significantly between the treated and untreated group. 
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Figure 3. Caecal (A, B, C) and spleen (D, E, F) colonisation by a Salmonella Enteritidis, Salmonella 
Typhimurium or Salmonella Paratyphi B var. Java challenge strain. Animals from groups VSE, VST and VSJ 
were orally inoculated with a combination of 10
8
 CFU of a Salmonella Enteritidis ΔhilAssrAfliG strain and 10
8
 
CFU of a Salmonella Typhimurium ΔhilAssrAfliG strain at day 1 of the experiment (day-of-hatch). All groups 
were infected with 10
5
 CFU of a challenge strain on day 2 of the experiment. Groups CSE and VSE were infected 
with a Salmonella Enteritidis challenge strain (A, D), groups CST and VST with a Salmonella Typhimurium strain 
(B, E) and groups CSJ and VSJ with a Salmonella Paratyphi B var. Java strain (C, F). Samples were taken at day 7 
of the experiment. Represented values are log10 of CFU/g sample. The horizontal lines represent the mean, the 
error bars represent the standard error of mean (SEM). The number of samples equals 10 in every group. 
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Discussion 
 
Newly hatched chicks are highly susceptible to Salmonella infections during the first days of 
life and inoculation with very low doses can result in persistent infections [159-161]. This 
high susceptibility has been associated with the absence of normal gut microbiota [197, 198] 
and the immature immune system of young chickens [156, 157, 199]. As a consequence, 
classical vaccination is not an effective means to achieve protection against Salmonella 
infection during the first days of life [133]. Alternatively, the use of organic acids, essential 
oils, pro- and prebiotics as feed supplements can help to control Salmonella infections in 
broiler chickens, but the protective responses elicited by these compounds only start several 
days post-hatch [116, 202, 203]. Since a rapid colonisation-inhibiting effect has been 
described in birds inoculated with a live Salmonella strain that protected the animals against 
subsequent challenge with another Salmonella strain, administration of CI strains to chickens 
early post-hatch might be a valuable addition to these strategies. 
 
The Salmonella Typhimurium ΔhilAssrAfliG strain used in the present study was very 
effective at protecting against Salmonella Typhimurium challenge. Unfortunately, the 
Salmonella Typhimurium ΔhilAssrAfliG strain was highly colonising and persisted in the 
caecum until slaughter age when the chickens were not challenged with a wild-type strain. 
However, when challenging the chickens with a wild-type strain, the Salmonella 
Typhimurium ΔhilAssrAfliG strain was cleared rapidly from the chickens. This suggests an 
interaction between both strains that influences persistence and clearance of the CI strain 
from the chickens. Still, because this might result in the introduction of the deletion mutant 
strain in the food chain when applied in the field, the developed CI strain might not be an 
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appropriate candidate for use in broiler production. As the ability of Salmonella strains to 
colonise represents an important prerequisite for effective colonisation inhibition of wild-
type strains, persistence of a CI strain and protection offered by a CI strain are probably 
related to each other. Furthermore, it has been suggested that a CI strain is more protective 
against challenge when it is highly colonising [169, 173]. It is therefore not improbable that 
the observed strong protective effect of the Salmonella Typhimurium ΔhilAssrAfliG strain is 
due to its high colonising capacity. A Salmonella Enteritidis hilAssrAfliG deletion mutant has 
been shown to colonise spleen and caecum to a lesser extent and was cleared rapidly from 
poultry, but also offered relatively less protection against Salmonella Enteritidis infection 
[204]. These and earlier observations suggest thus that there will be a trade-off between 
persistence and protection, as a highly colonising and thus protective strain will probably not 
be eliminated by slaughter age [190]. In contrast, a strain that is poorly colonising will be 
eliminated by slaughter age, but will probably not offer a long lasting protection. Obviously, 
these aspects should be taken into account when developing a CI strain. 
 
Earlier research showed that the colonisation-inhibition effect is more pronounced between 
isogenic strains and that there is greater inhibition within a serovar than between serovars 
[133, 169, 183]. Consequently, it is likely that the Salmonella Typhimurium ΔhilAssrAfliG 
strain is not able to inhibit strains belonging to other serovars than Typhimurium. It has 
however been suggested that a mixture of Salmonella strains belonging to several serovars 
would be able to inhibit a broad spectrum of virulent wild-type strains [169]. Therefore, we 
investigated the protective properties of a mixed culture consisting of both the Salmonella 
Enteritidis and Typhimurium ΔhilAssrAfliG strain against infection by 3 different Salmonella 
serovars. The results obtained in this study showed that the combined CI culture confers 
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protection against a non-isogenic Salmonella Enteritidis and Salmonella Typhimurium 
challenge strain quickly after hatching. This suggests that both CI strains do not inhibit each 
other, or if they do it is to such a limited extent that they do not impede each other’s 
protective properties. Earlier research showed that administering a mixture consisting of a 
wild-type Salmonella Enteritidis and Salmonella Typhimurium strain resulted in a 
pronounced protection against their isogenic challenge strains, but also against Salmonella 
Hadar and Salmonella Infantis challenge strains [169]. This suggests a synergistic protective 
effect when administering multiple CI strains simultaneously. In the present study, the CI 
mixture consisting of the Salmonella Enteritidis ΔhilAssrAfliG strain and Salmonella 
Typhimurium ΔhilAssrAfliG strain did, however, not offer protection against challenge with a 
Salmonella Paratyphi B. var. Java strain. Consequently, this suggests that a Salmonella 
Paratyphi B. var. Java CI strain needs to be developed and added to the CI culture in order to 
achieve simultaneous protection against Salmonella Enteritidis, Typhimurium and Paratyphi 
B. var. Java infection. 
 
In conclusion, a significant reduction in faecal shedding and caecal and internal organ 
colonisation by a virulent Salmonella Typhimurium challenge strain could be obtained by 
administering a Salmonella Typhimurium ΔhilAssrAfliG mutant strain to one day old broiler 
chickens. Additionally, when this strain was administered simultaneously with a Salmonella 
Enteritidis hilAssrAfliG deletion mutant protection against infection by both a Salmonella 
Enteritidis and Typhimurium challenge strain could be obtained. These data demonstrate 
that colonisation-inhibition represents a promising tool to protect broilers early after 
hatching against multiple Salmonella serotypes. They pave the way for developing new CI 
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strains and CI cultures that are cleared at slaughter age and protect against a wide variety of 
Salmonella serovars that are of importance for broiler production. 
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Abstract 
 
Consumption of contaminated poultry meat is still an important cause of Salmonella 
infections in humans. Colonization-inhibition (CI) occurs when a live Salmonella strain is 
administered to chickens and subsequently protects against challenge with another 
Salmonella strain belonging to the same serovar. A Salmonella Enteritidis hilAssrAfliG 
deletion mutant has previously been proven to reduce colonization and shedding of a wild-
type Salmonella Enteritidis strain in newly hatched broilers after experimental infection. In 
this study, we compared two administration routes for this strain. Administering the 
Salmonella Enteritidis ΔhilAssrAfliG strain through drinking water on the first day of life 
resulted in a decreased faecal shedding and caecal colonization of a wild-type Salmonella 
Enteritidis challenge strain administered 24 h later using a seeder-bird model. When 
administering the CI strain by coarse spray on newly hatched broiler chicks, an even more 
pronounced reduction of caecal colonisation was observed and faecal shedding of the 
Salmonella Enteritidis challenge strain ceased during the course of the experiment. These 
data suggest that administering a Salmonella Enteritidis ΔhilAssrAfliG strain to newly 
hatched chicks using a coarse spray is a useful and effective method which reduces 
colonization and shedding of a wild-type Salmonella Enteritidis strain after early challenge.  
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Introduction 
 
Despite the implementation of monitoring and control measures in broiler production, 
poultry meat is still an important carrier of Salmonella causing human infections [5]. 
Chickens are highly susceptible to Salmonella infection during their first days of life [159] and 
contact with Salmonella, even in very low numbers, can lead to persistent infections [160, 
161]. These broilers often remain infected until slaughter age, which leads to introduction of 
Salmonella in the slaughterhouse and food chain [14]. Consequently, prevention of infection 
during the early post-hatch period is of utmost importance. Colonization-inhibition (CI) 
occurs when a live Salmonella strain is orally administered to day-old chickens: it protects 
very rapidly against subsequent challenge with another Salmonella strain belonging to the 
same serotype [171, 173, 189, 191]. CI can thus be used as control method to prevent 
infection during the period in which the chick is highly susceptible to Salmonella infection 
[189]. Earlier research demonstrated that deletion of the hilA, ssrA and fliG genes in a 
Salmonella enterica subspecies enterica serovar Enteritidis (Salmonella Enteritidis) strain 
resulted in a CI strain that was safe and effective in protecting broilers against challenge with 
a Salmonella Enteritidis wild-type strain [204]. This strain is considered safe because it is 
cleared by slaughter age and effective, as it lowers faecal shedding and caecal colonization 
of a wild-type Salmonella Enteritidis challenge strain. In this earlier study, the CI strain was 
administered by oral gavage in the crop, which is an unrealistic administration method in 
practice on a large scale. Because the level of protection offered by a CI strain is dependent 
on the administration route [133], the efficacy of the Salmonella Enteritidis ΔhilAssrAfliG 
strain might be different when this strain is administered by other routes than the oral 
gavage. Therefore, two practically relevant administration routes for the Salmonella 
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Enteritidis hilAssrAfliG deletion mutant, through drinking water and by coarse spray, were 
investigated and compared in this study. 
 
Materials and methods 
 
Chickens 
One-day-old Ross 308 broiler chicks were obtained from a local hatchery and housed in 
isolation. Experimental groups were housed in separate rooms in containers on wood 
shavings. Commercial feed and drinking water were provided ad libitum. Cloacal swabs of all 
chicks were taken at the beginning of the experiment and cultured for Salmonella as 
described below to verify Salmonella-free status of the chickens prior to the experiment. 
Experiments were performed with the permission of the Ethical Committee of the Faculty of 
Veterinary Medicine, Ghent University, Belgium (experiment authorization number: 
EC2013/136). 
 
Salmonella Enteritidis strains 
Salmonella Enteritidis 76Sa88 is a nalidixic acid resistant, well-characterized strain originally 
isolated on a poultry farm [159, 193]. It was used for the production of isogenic mutants. 
Deletion of hilA, ssrA and fliG genes was done using the one-step inactivation method 
described by Datsenko and Wanner [194]. Salmonella Enteritidis 147, a streptomycin 
resistant strain originally isolated from egg white, was used as a challenge strain. This strain 
is known to colonize the gut and internal organs of chickens to a high level [189, 195, 196]. 
 
Chapter 3.3  Experimental Study 3 
98 
Experimental design 
One hundred and eighty one-day-old chicks were divided into 3 groups of 60 and each 
housed in a container of two m2. The first group (Group C) was given sterile Hank’s Balanced 
Salt Solution (HBSS, 14175053, Invitrogen, Paisley, England) by oral gavage as a control on 
the first day of the experiment. Group D was given access to drinking water that contained 
initially 7.03 x 108 CFU/ml of the Salmonella Enteritidis ΔhilAssrAfliG strain for the first 24 h 
of the experiment. The chicks in Group S were transferred to a box (measuring 40 cm on 60 
cm) and sprayed with 125 ml of a 7.28 x 108 CFU/ml solution of the Salmonella Enteritidis 
ΔhilAssrAfliG strain using a coarse spray. They were transferred to their containers 10 
minutes after treatment. On the second day of the experiment, 12 chickens in each group (1 
out of 5) were randomly selected and given 105 CFU of the Salmonella Enteritidis challenge 
strain (seeder birds) by oral gavage and housed together again with the other animals of 
their group. To evaluate colonization by the Salmonella Enteritidis ΔhilAssrAfliG strain and 
the wild-type challenge strain, their numbers in caecum and spleen were determined on 
days 7, 21 and 42 for 20 chickens. At each time point, one in five sampled animals were 
seeder birds. Shedding of both strains was evaluated during the experiment by 
bacteriological analysis of cloacal swabs taken on days 2, 3, 9, 16, 23, 30 and 37. 
 
Bacteriological analysis 
Cloacal swabs were directly inoculated on Xylose Lysine Deoxycholate agar (XLD, CM0469, 
Oxoid, Basingstoke, England) plates supplemented with 20 µg/ml nalidixic acid (N8878, 
Sigma-Aldrich, St. Louis, MO, USA) or 100 µg/ml streptomycin (S6501, Sigma-Aldrich, St. 
Louis, MO, USA). Samples negative after direct inoculation were pre-enriched in Buffered 
Peptone Water (BPW, CM0509, Oxoid, Basingstoke, England) and incubated overnight at 37 
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°C. One ml of this suspension was further enriched by adding 9 ml tetrathionate-brilliant 
green broth (1.05178.0500, Merck, Darmstadt, Germany). After overnight incubation at 37 
°C, this suspension was plated on XLD plates with the appropriate antibiotic. 
Samples of caecum and spleen were homogenized in BPW and 10-fold dilutions were made 
in HBSS. Six droplets of 20 µl of each dilution were plated on XLD plates supplemented with 
the appropriate antibiotic. After overnight incubation at 37 °C, the number of CFU/g tissue 
was determined by counting the number of bacterial colonies. Negative samples were 
enriched as described above. Samples of the litter were taken after termination of the 
experiment and enriched as described above. 
 
Statistical analysis 
GraphPad Prism 5 software was used for statistical analysis. A Fisher’s exact test (one-sided) 
was used to analyze differences in mortality between groups. A Kruskal-Wallis test (one-way 
ANOVA, with Dunn’s multiple comparison test) was used to determine statistical differences 
of the number of Salmonella positive cloaca swabs and (after enrichment) spleen and 
caecum samples, between groups. Bacterial counts in caecum and spleen were converted 
into logarithmic form for statistical analysis. Samples of caecum and spleen negative after 
direct plating were rated as log10= 0. Differences between groups were analyzed using a 
Kruskal-Wallis test (one-way ANOVA, with Dunn’s multiple comparison test). Differences 
with p-values lower than 0.05 were considered to be significant. 
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Results 
 
In every group 5 chickens died during the course of the experiment. Consequently, there is 
no statistical difference between groups in mortality. As shown in Table 1, shedding of the 
Salmonella Enteritidis ΔhilAssrAfliG strain declined in both groups after inoculation, and the 
strain was no longer shed from day 23 of age onwards. Shedding of the Salmonella 
Enteritidis challenge strain was lower in Group S than in Group C for the entire duration of 
the experiment, while there was only initially a difference between Group C and D.  
 
Table 1. The number of cloacal swabs positive for a Salmonella Enteritidis ΔhilAssrAfliG strain or a 
Salmonella Enteritidis challenge strain. Group C was given sterile HBSS as a control on day 1. Group S was 
sprayed with 125 ml of a suspension containing ± 10
9
 CFU/ml Salmonella Enteritidis ΔhilAssrAfliG strain on day 
1. Group D was given access to drinking water containing ± 10
9
 CFU/ml of a Salmonella Enteritidis ΔhilAssrAfliG 
strain for the first 24 h of the experiment. Twelve chickens in each group (1 out of 5) were challenged with 10
5
 
CFU of a Salmonella Enteritidis challenge strain on day 2 of the experiment (seeder birds). Samples were taken 
at days 2, 3, 9, 16, 23, 30 and 37 of the experiment.
 
Strain Group Day 2 Day 3 Day 9 Day 16 Day 23 Day 30 Day 37 
ΔhilAssrAfliG 
S 60/60
a
 (54
b
*) 57/59 (43*) 22/38 (4) 2/37 (0) 0/19 (0) 0/19 (0) 0/18 (0) 
D 55/60 (29*) 57/59 (22*) 17/38 (7) 12/38 (1) 0/18 (0) 0/18 (0) 0/17 (0) 
Challenge 
C NA 12/60 (6) 39/39* (28*) 27/37* (8) 3/18 (0) 4/16 (2) 6/16 (3) 
S NA 6/59 (3) 8/38* (0*) 1/37* (0) 0/19 (0) 0/19 (0) 0/18 (0) 
D NA 8/59 (2) 8/38* (1*) 22/38 (7) 4/18 (2) 7/18 (2) 5/17 (2) 
a
 Number of positive samples after enrichment/total number of samples 
b
 Number of positive samples after direct plating 
* Significant difference between groups (p-value < 0.05) 
NA = Not available 
 
Colonization by the Salmonella Enteritidis ΔhilAssrAfliG strain was initially high in the 
caecum, where the bacterial load amounted to 6.67 ± 0.029 log CFU/g and 6.82 ± 0.115 log 
CFU/g after direct plating, respectively in Groups S and D on day 7 of the experiment. On day 
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21, the CI strain could not be detected after direct plating in any sample belonging to Group 
S and only one sample was positive in Group D for which the bacterial load amounted to 
4.28 log CFU/g. The CI strain could not be detected after direct plating in any of the caecum 
samples on day 42 or spleen samples for the entire duration of the experiment. Colonization 
by the Salmonella Enteritidis challenge strain is shown in Figure 1. Colonization of the 
caecum was significantly lower in Group S than in Group C for the entire duration of the 
experiment. Colonization of the caecum in Group D was significantly lower than the control 
group on day 7 and 42. There was no difference between the mean log CFU/g spleen of the 
different groups at any time point. 
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Figure 1. Caecal (A, B, C) and spleen (D, E, F) colonization by a Salmonella Enteritidis challenge strain. Group C 
was given sterile HBSS as a control on day 1. Group S was sprayed with a suspension containing a Salmonella 
Enteritidis ΔhilAssrAfliG strain on day 1. Group D was given access to drinking water containing a Salmonella 
Enteritidis ΔhilAssrAfliG strain for the first 24 h of the experiment. Twelve chickens in each group (1 out of 5) 
were challenged with a Salmonella Enteritidis challenge strain on day 2 of the experiment (seeder birds). 
Subfigures A and D show colonization on day 7, B and E on day 21 and C and F on day 42. Values shown are 
log10 of CFU/g sample. The horizontal lines represent the mean, the error bars represent the standard error of 
mean (SEM). Significant differences between groups are indicated with * (p-value < 0.05). 
 
Enrichment of caecum and spleen samples showed that the Salmonella Enteritidis 
ΔhilAssrAfliG strain was present in only a few samples at day 21 of the experiment, and could no 
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longer be detected at day 42 (Table 2). The number of caecum and spleen samples positive for the 
Salmonella Enteritidis challenge strain was lower in both Group S and D than in Group C. However, 
this difference was only statistically significant on day 42 for the caecum when comparing Group S to 
the control group. The Salmonella Enteritidis ΔhilAssrAfliG strain could not be detected after 
enrichment of the litter samples. The Salmonella Enteritidis challenge strain could be detected in the 
litter of Group C, but was not present in the litter of the treated groups. 
 
Table 2. The number of caeca and spleen samples positive for a Salmonella Enteritidis ΔhilAssrAfliG strain or 
a Salmonella Enteritidis challenge strain after enrichment. Group C was given sterile HBSS as a control on day 
1. Group S was sprayed with 125 ml of a suspension containing ± 10
9
 CFU/ml Salmonella Enteritidis 
ΔhilAssrAfliG strain on day 1. Group D was given access to drinking water containing ± 10
9
 CFU/ml of a 
Salmonella Enteritidis ΔhilAssrAfliG strain for the first 24 h of the experiment. Twelve chickens in each group (1 
out of 5) were challenged with 10
5
 CFU of a Salmonella Enteritidis challenge strain on day 2 of the experiment 
(seeder birds). Samples were taken at days 7, 21 and 42 of the experiment.
 
Day 
Salmonella Enteritidis ΔhilAssrAfliG strain Salmonella Enteritidis challenge strain 
Caecum Spleen Caecum Spleen 
Group S Group D Group S Group D Group C Group S Group D Group C Group S Group D 
7 16
a
/19
b
 16/20 16/18 9/20 20/20 14/19 14/20 11/20 5/18 6/20 
21 3/18 1/18 0/18 0/18 19/19 12/18 16/18 19/19* 5/18* 11/18 
42 0/18 0/17 0/18 0/17 16/16* 1/18* 15/17 7/16 3/18 3/17 
a
 Number of positive samples after enrichment 
b
 Total number of samples 
* Significant difference between groups (p-value < 0.05) 
 
Discussion 
 
Recent research demonstrated that a Salmonella Enteritidis hilAssrAfliG deletion mutant is a 
CI strain that lowers colonization of a Salmonella Enteritidis wild-type strain after 
experimental infection. In addition, this deletion mutant could not be detected anymore at 
slaughter age [204]. Because the level of protection offered by live vaccine strains is 
Chapter 3.3  Experimental Study 3 
104 
dependent on the administration route [133], two practically relevant administration 
methods for the Salmonella Enteritidis ΔhilAssrAfliG strain were investigated in this study. 
Only one Salmonella Enteritidis challenge strain was used in this study, as protection offered 
by colonization-inhibition is often similar for heterologous strains within the same serovar 
[169]. Neither of both administration methods investigated in this study offered protection 
against mortality caused by the Salmonella Enteritidis challenge strain, as there was no 
significant difference in mortality between the untreated group and treated groups. 
However, by adding the Salmonella Enteritidis ΔhilAssrAfliG strain to the drinking water, a 
significant reduction in colonization of the caecum could be obtained by slaughter age and 
shedding of the wild-type strain was reduced during the course of the experiment. An even 
more distinct reduction of caecal colonization was obtained when administering the strain 
by coarse spray and this also resulted in a significantly higher number of caeca negative for 
the wild-type strain. Additionally, shedding of the challenge strain ceased during the course 
of the experiment in the spray-treated group. This may be because spraying allows a more 
uniform and simultaneous distribution of the CI strain amongst the chickens, as spraying 
results in the formation of droplets on the birds which are taken up orally quickly after 
administration during preening [206, 207]. Recent research has however suggested the 
respiratory route as a viable route of entry for Salmonella in poultry [34]. Consequently, it is 
possible that the CI strain is also taken up through the respiratory route when spraying it. 
Additionally, spraying newly hatched chicks ensures better uptake of the CI strain quickly 
after hatching. In contrast, drinking water consumption may vary during the first days of life 
[208], which might result in a more variable uptake of the CI strain and consequently a more 
variable level of protection. However, both administration methods resulted in oral uptake 
of the strain and ultimately in the presence of the strain in the caeca of the chickens. This is 
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essential for colonization-inhibition, as the presence of the CI strain is required to inhibit 
growth of the wild-type strain [209, 210].  
 
We conclude that the Salmonella Enteritidis ΔhilAssrAfliG strain should ideally be 
administered to newly hatched chicks using a coarse spray for the purpose of colonization-
inhibition, as this resulted in the most profound reduction in caecal colonization and faecal 
shedding of a wild-type Salmonella Enteritidis strain in an early challenge model. 
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4 General discussion and conclusions 
 
Salmonella contamination rates in poultry have declined drastically the past decade in the 
European Union thanks to the implication of member state control programs. One of the 
most important measures in the control programs of many member states was the 
obligatory vaccination of laying hens, which has reduced the incidence of Salmonella 
contaminated eggs and consequently the introduction of Salmonella in the food chain. 
Poultry meat is however often still contaminated with Salmonella [5], thus forming a 
possible source of Salmonella infections. Poultry meat contamination is often the 
consequence of an infection early in the chicken life, as young broiler chicks are highly 
susceptible to Salmonella infections [159-161]. Infection with Salmonella during this period 
can result in persistent infections which, despite currently implied control measures, can 
ultimately result in the contamination of poultry meat. In addition, it is difficult to establish 
protection early in the chicken life. Classical vaccination of one day old chicks does not 
induce production of significant amounts of specific antibodies against Salmonella until the 
animals are 10 days old [211-213]. Feed or drinking water additives have shown to decrease 
Salmonella colonization levels but not to eliminate the bacterium from the host [133]. CI, 
offering protection early in the chicken life, could thus be a potentially powerful tool for the 
poultry industry that can be used to decrease colonization levels and shedding of Salmonella 
in the environment. 
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4.1 Consequences of hilA, ssrA and fliG mutations in Salmonella Enteritidis 
 
By introducing the hilA, ssrA and fliG mutations in a Salmonella Enteritidis strain we obtained 
a strain that combines several of the characteristics of the single mutants. Due to the 
mutation in hilA, the Salmonella Enteritidis hilAssrAfliG deletion mutant is a strain that is 
severely impaired in the invasion of epithelial cells, since hilA is a crucial regulator for SPI-1 
and the genes associated with invasion [81]. As hilA is involved in the long-term shedding 
and colonization by Salmonella Enteritidis, deletion of this gene contributes strongly to the 
rapid clearing of the CI strain [81]. A possible explanation for this is that Salmonella bacteria 
multiply intracellular in the epithelial cells of the caeca, and are subsequently released into 
the lumen after death of the infected epithelial cells [81]. As the hilA deletion mutants are 
no longer able to invade the epithelial cells in a SPI-1 mediated way, they will not be able to 
proliferate in the GIT. The hilA strain is however not fully impaired for invasion, as other 
mechanisms are available for Salmonella to enter epithelial GIT cells [54, 60, 61, 63, 214]. 
This is confirmed by earlier observations, as the Salmonella Enteritidis ΔhilA strain can still 
be isolated from internal organs after oral inoculation, indicating that this strain is still able 
to invade epithelial cells, although to a significantly lower extent than its wild-type 
counterpart [81, 189, 190]. This will also be the case for the Salmonella Enteritidis 
ΔhilAssrAfliG strain, but as other mutations attenuate this strain further, its remaining 
virulence will be diminished as well. 
 
Mutation of the ssrA gene in Salmonella Enteritidis results in a strain that is fully invasive in 
phagocytic and non-phagocytic cells, but fails to persist within chicken macrophages [86]. 
When introducing the ssrA mutation in a Salmonella Enteritidis ΔhilA strain, the resulting 
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strain is severely impaired in cellular invasion due to the hilA mutation, but also no longer 
able to persist within chicken macrophages due to the ssrA mutation [86]. Because of the 
ssrA mutation, these bacteria lack a functional SPI-2 T3SS, are therefore unable to 
translocate any effectors in the SCV and remain within an immature SCV that does not form 
membrane tubules and is defective at juxtanuclear positioning [215, 216]. In addition, these 
mutants show a replication defect in both macrophages and epithelial cells [215, 217, 218], 
severely reducing intestinal Salmonella propagation and systemic spread. However, recent 
evidence has shown that a proportion of intracellular Salmonella bacteria can escape from 
the SCV and replicate efficiently in the cytosol of epithelial cells, contributing to Salmonella 
propagation [215]. These cytosolic and vacuolar Salmonella populations are transcriptionally 
distinct as well, as the intravacuolar bacteria are SPI-2 induced while the cytosolic bacteria 
are SPI-1 induced and flagellated [215]. Epithelial cells containing hyper-replicating SPI-1 
induced Salmonella bacteria undergo caspase-induced inflammatory cell death and are 
extruded from monolayers, a process in which the invasion-primed Salmonella are released 
in the extracellular milieu and are able to spread and infect additional cells [215, 218]. Due 
to the mutation in hilA, the Salmonella Enteritidis hilAssrAfliG deletion mutant’s capability to 
invade epithelial cells is severely impaired and as a consequence, this process in which 
cytosolic Salmonella invade additional cells upon release is severely impaired as well. This 
could also, at least partially, explain the rapid elimination of the Salmonella Enteritidis 
ΔhilAssrAfliG strain from the host and contributes to the strongly reduced virulence 
compared to the wild-type parent strain. 
 
In addition to the hilA and ssrA mutations, deletion of the fliG gene also contributes to the 
reduced virulence of the Salmonella Enteritidis triple deletion mutant, as invasion requires 
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not only the SPI-1 T3SS but flagellar-based motility as well [219, 220]. On the other hand, it 
has been shown that an aflagellar Salmonella Typhimurium fliM mutant exhibited an 
enhanced ability to establish systemic infection, and that it induced less IL-1β mRNA 
production and polymorphonuclear cell infiltration of the gut when compared to a wild-type 
strain during the initial stages of infection [221]. This enhanced ability to establish systemic 
infection was however only short-lived, and was probably related to an ability to evade early 
host recognition [222]. Flagellin is in fact an important and well-known TLR5 agonist and, as 
TLR5 is believed to play a key role in the initiation of inflammatory responses, the absence of 
flagella has an effect on the chicken immune response [221, 223]. The developed Salmonella 
Enteritidis ΔhilAssrAfliG strain does however not display an early, short-lived enhanced 
ability to establish systemic infection in broilers, presumably because the deletion of other 
important virulence genes renders the Salmonella Enteritidis ΔhilAssrAfliG strain severely 
attenuated. Deletion of the fliG gene thus results in a CI strain that no longer produces 
functional flagella and renders the strain immotile. This aspect of the CI strain has important 
consequences, as this allows for the distinction between vaccinated and infected animals 
when administering the strain to animals [165]. Firstly, because the strain is no longer 
motile, it can easily be differentiated from wild-type Salmonella Enteritidis strains using a 
motility test (such as Modified Semi-solid Rappaport-Vassiliadis (MSRV)). As such, it will not 
interfere with most Salmonella testing procedures, as these often comprise a motility test 
(ISO 6579:2002/Amd1:2007 Annex D). In addition, the deletion mutant strains can easily be 
differentiated from wild-type Salmonella strains using PCR, as the deleted genes can be used 
as targets to differentiate between both. Secondly, as the strain no longer produces 
functional flagellin, administering this strain to an animal would not induce an anti-flagellin 
immune response. A wild-type Salmonella strain on the other hand, expressing flagellar 
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antigens, does induce an anti-flagellin immune response after infection, which can be used 
to distinguish animals that are treated with the CI strain from those that are infected with a 
wild-type strain. It is even possible that the Salmonella Enteritidis ΔhilAssrAfliG strain does 
not induce an immune response at all, as it is cleared early in the chickens life and thus 
cleared before an effective immune response can be mounted. On the other hand, because 
it is possible that the Salmonella Enteritidis ΔhilAssrAfliG strain does not induce an immune 
response when administered to recently hatched chickens, it might not offer additional 
protection against Salmonella infection other than its colonization-inhibition effect. 
However, if this strain is administered to more mature animals with a more mature and fully 
functioning immune system (e.g. using a triple dose vaccination in layers), a protective 
immune response against Salmonella infections could possibly be induced by the CI strain. 
Combination of the hilAssrAfliG mutations in Salmonella Enteritidis results thus in a strongly 
attenuated strain that is strongly impaired for invasion and intracellular survival, yet 
maintains its CI potential. 
 
Most research concerning the role of Salmonella hilA and ssrA genes in poultry infections 
haven been investigated for Salmonella Enteritidis [81, 86, 189, 190]. The results obtained in 
Chapter 3.2 have shown that introducing these mutations in a Salmonella Typhimurium 
strain does not result in an equally attenuated strain, as the Salmonella Typhimurium 
hilAssrAfliG deletion mutant is still shed at slaughter age and colonizes the GIT persistently, 
illustrating the importance of the genetic background in which the mutations are introduced. 
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4.2 Safety aspects for CI and live vaccine strains 
 
The prolonged persistence of the Salmonella Typhimurium hilAssrAfliG deletion mutant 
strain, described in the third chapter (3.2), has consequences for possible practical 
application, as an important prerequisite for CI strains and live vaccine strains in general, is 
that these strains should be cleared by slaughter age to avoid the introduction of these 
strains in the food chain. While this is the case for the Salmonella Entertidis hilAssrAfliG 
deletion mutant, it is not for the Salmonella Typhimurium hilAssrAfliG deletion mutant 
strain. As the latter strain can still be detected by slaughter age and is still present at high 
levels in the caecum at 42 weeks of age, its use in broiler practice should be avoided as this 
could result in the introduction of this strain in the food chain. It might however be possible 
to administer this strain in a lower dose, which could result in an earlier clearance, or 
introduce additional mutations to reduce persistence and colonization rate even further. 
One could argue that, due to the deletions in hilA and ssrA, this strain should be safe for 
humans and introduction of this strain in the food chain does not imply a safety risk for 
human health. Additionally, the introduced mutations might reduce the ability of the 
Salmonella Typhimurium ΔhilAssrAfliG strain to survive on the boiler carcass after slaughter, 
meaning that it is possible that the strain would not be introduced in the food chain even if it 
is still present in the animal at slaughter age. This has however not been investigated yet and 
use of this CI strain in its current form in broiler practice might thus comprise a safety risk for 
human health. As such, public and government would not accept the use of this live 
Salmonella vaccine strain that could possibly become introduced in the food chain. 
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One major advantage of both the Salmonella Enteritidis hilAssrAfliG deletion mutant strain 
and the Salmonella Typhimurium hilAssrAfliG deletion mutant strain, and in general, live 
vaccines that are deletion mutants, is that these strains cannot revert back to their virulent 
wild-type parent strain. The live vaccines that are currently available to protect poultry 
against Salmonella were often developed by chemical mutagenesis or are metabolic drift 
mutants [150]. The latter are produced by isolating strains that have a longer generation 
time (thus producing smaller colonies) and a corresponding reduced virulence. These 
mutations are however unfixed, and there is a small chance of reversion to the original 
virulent wild-type. In addition, it is often not known where these mutations are situated in 
the genome or how attenuation is achieved. A Salmonella Gallinarum mutant (SG9R), which 
was originally used to protect poultry against fowl typhoid, offers protection against 
Salmonella Enteritidis as well and consequently, was sometimes used in practice to protect 
poultry against Salmonella Enteritidis infection. It is however strongly suspected that the 
SG9R strain has been the cause of fowl typhoid outbreaks in poultry, due to reversion of the 
strain to a virulent phenotype [167, 224]. Research has shown that a single nucleotide 
nonsense mutation of rfaJ can again confer virulence to the SG9R strain [224] and that 
different Salmonella Gallinarum field strain isolates are closely related to the SG9R vaccine 
strain, suggesting that the Salmonella Gallinarum field strain is a SG9R strain that regained 
its virulence [167]. Such mutations associated with reversion arise at a low frequency, yet 
may become quickly fixed in the population if there is a strong selection pressure for 
virulence and eventually lead to sporadic outbreaks of the virulent strain [167]. This risk of 
reversion can be outweighed by the benefits of decreasing the number of outbreaks in 
regions with a high infection pressure from field strains. However, the genetic tools to delete 
whole and multiple genes are readily available, and can be used to limit the chance of 
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reversion to virulence by developing well-defined genetically modified live vaccine strains. 
Despite that this allows for the development of safer strains, these well-defined deletion 
mutants might raise consumer concerns as they are genetically modified organisms. 
 
In addition to the reduced chance of reverting back to their virulent phenotype, the 
developed CI strains also possess other advantages when compared to the live vaccines that 
are currently available for use in poultry practice. The CI strains developed in these studies 
are resistant to the antibiotic nalidixic acid, which facilitated their isolation and enumeration 
during the in vivo trials. It is however also possible to generate CI strains that share the same 
characteristics of the developed CI strains, yet are not resistant to any antibiotic. As there 
are concerns that antibiotic resistant live vaccine strains could contribute to the spread of 
antibiotic resistance markers in the microbial community, the absence of such antibiotic 
resistance markers in CI strains or live vaccine strains confers them another advantage over 
the currently available live vaccines (which often are resistant to one or more antibiotics). 
Finally, it is not unlikely that the currently commercially available live vaccine strains are able 
to induce a CI effect as well (see Chapter 1), and could thus also be used to protect broilers 
against Salmonella early in life. However, because most of these commercially available live 
vaccine strains were developed for use in layers, their safety and short-term efficacy when 
applied to young broilers is often unknown. The developed CI strains were, in contrast, 
designed for use in broilers and as such, were tested for both their safety and efficacy in 
broilers. As a consequence, applicable CI strains are thus more suited to protect broilers 
quickly post-hatch against early Salmonella challenge while being cleared by slaughter age. 
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4.3 Protection against a broad spectrum of Salmonella serotypes using CI 
 
Earlier research showed that colonisation-inhibition is more pronounced between isogenic 
strains and that there is greater inhibition within a serovar than between serovars [133, 169, 
183]. In accordance with these observations, we found that that the Salmonella Enteritidis 
and Typhimurium deletion mutant strains are able to inhibit strains belonging to their 
respective serovar, but were not able to inhibit a Salmonella Paratyphi B var. Java strain. This 
also explains why the Salmonella Enteritidis hilAssrAfliG deletion mutant strain and the 
Salmonella Typhimurium hilAssrAfliG deletion mutant strain do not inhibit each other 
(Chapter 3.2), and are able to still offer protection against both Salmonella Entertidis and 
Typhimurium after simultaneous administration. This also has practical implications, because 
this means that multiple serotype preparations can be produced that are protective against 
multiple Salmonella serovars. It has been suggested that a mixture of Salmonella CI strains 
belonging to several serovars could be able to inhibit a broad spectrum of virulent wild-type 
strains, as a mixture consisting of a wild-type Salmonella Enteritidis and Salmonella 
Typhimurium strain not only protects against their isogenic challenge strains, but against 
Salmonella Hadar and Salmonella Infantis challenge strains as well [169]. This suggests a 
synergistic protective effect when administering multiple CI strains simultaneously, yet this is 
not observed in our studies. The combined CI culture consisting of the Salmonella Enteritidis 
ΔhilAssrAfliG strain and Salmonella Typhimurium ΔhilAssrAfliG strain does not offer 
protection against infection with Salmonella Paratyphi B var. Java, suggesting a Salmonella 
Paratyphi B var. Java deletion mutant needs to be developed in order to obtain a CI strain 
protecting against this serotype. 
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Because methods have been developed to easily and quickly develop Salmonella deletion 
mutants [194], it is possible to quickly generate new mutants belonging to other serovars of 
importance for broiler production. Such an approach might however be more difficult than 
expected, as the introduced mutations might not always result in the same level of 
attenuation in the different Salmonella serovars. In Chapter 3.2, we observed a difference 
between the Salmonella Enteritidis hilAssrAfliG deletion mutant strain and the Salmonella 
Typhimurium hilAssrAfliG deletion mutant strain in persistence and colonization rate, while 
both strains were anticipated to be attenuated to the same extent as the same genes were 
deleted in both strains. This difference in persistence and colonization rate for the CI strains 
could be explained by the different genetic background in which the mutations are 
introduced, and might thus be dependent on the Salmonella serovar or even strains in which 
the mutations are introduced [169]. These observations underline the importance of the 
genetic background in which the deletions are introduced, and that, in order to obtain the 
same level of attenuation, additional or even different mutations might need to be 
introduced in different CI strains. 
 
4.4 Practical relevance and compatibility with implemented Salmonella control 
measures 
 
When considering the practical relevance of the developed CI strains, an important aspect 
for the Salmonella Enteritidis hilAssrAfliG deletion mutant strain is the in Chapter 3.3 
suggested reduced environmental persistence. The deletion mutant strain could not be 
found again in the litter on which the treated birds were housed after the end of the 
experiment, which might indicate that this strain has reduced capabilities to survive and 
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persist in the environment. As a consequence, the risk of introducing a live CI strain in the 
environment would be avoided when using this strain in practice. 
 
Our research has also shown that it is possible to administer a Salmonella Enteritidis 
ΔhilAssrAfliG strain early after hatching using a coarse spray, which results in an early and 
sufficiently long lasting protection against Salmonella Enteritidis challenge. In practice, it 
would thus be possible to administer the CI strain before leaving the hatchery, conferring 
the chicks protection against Salmonella Enteritidis by the time they arrive on the farm 
(whilst avoiding the use of a live Salmonella vaccine on the farm itself). As young chicks often 
become infected upon introduction on the farm due to environmental contamination [19-
21, 23-28], Salmonella contamination could be further reduced if the chicks are protected 
before they are exposed to possible risk factors for Salmonella infection. Adding the 
Salmonella Enteritidis ΔhilAssrAfliG strain to the drinking water resulted only initially in a 
decrease in Salmonella Enteritidis shedding and colonization. In order to obtain a lasting 
protection, this could be combined with other control measures such as competitive 
exclusion treatment or by short chain fatty acid (SCFA) administration. This would however 
raise production cost and as drinking water is administered only after the chickens are 
already introduced on the farm, could imply exposure of the chickens to Salmonella before 
feeding and drinking water additives are administered. As application by coarse spray is an 
easy and cheap method offering early and lasting protection, administering CI strains in this 
manner is recommended. 
 
The observed difference in efficacy between the spray and drinking water treatment can 
possibly be explained by differences in uptake of the CI preparation. When administering the 
Chapter 4   General Discussion 
120 
CI strain using a spray, all chicks take up the CI strain within a very short period of time, that 
is, during the treatment itself and during preening, when chickens preen themselves [206, 
207]. As such, the CI strain can be administered quickly after hatching and there is time for 
the CI strain to colonize the gut before the chickens are exposed to Salmonella 
contamination on the farm. When administering the strain through the drinking water, it is 
possible that some chicks take up the CI strain later after hatching (as onset of thirst and 
thus drinking water uptake is variable) and there is less time for the CI strain to colonize the 
gut before chickens are infected, reducing the CI potential of the Salmonella Enteritidis 
ΔhilAssrAfliG strain. These birds will thus take up the CI strain, yet possibly too late to offer 
protection against the experimental Salmonella challenge. 
 
The implementation of other control measures on the farm might hamper the possible use 
of CI as an additional control method. Treating the chickens with a competitive exclusion 
product before administering the CI strain will drastically reduce colonization by the CI strain 
and consequently its CI potential [191]. On the other hand, when administering the CI strain 
prior to or simultaneously with a competitive exclusion product, they work synergistically 
and strongly reduce Salmonella colonization [191, 225]. Antibiotics can strongly reduce 
viability and consequently efficacy of a CI strain, but these compounds are prohibited in the 
European Union for control of Salmonella in broiler practice. Similarly, SCFA’s that are used 
as feed additives reduce Salmonella invasion [202], and are bacteriostatic or bactericidal for 
Salmonella in high concentrations. Administering these might lower CI strain colonization as 
well, and thus reduce CI potential of the strain. On the other hand, these control measures 
could contribute to faster clearing of CI strains that are not cleared by slaughter age under 
normal conditions, avoiding possible introduction of these CI strains in the food chain. In 
Chapter 4   General Discussion 
121 
addition, as the protective effect offered by CI is most important early after hatching and CI 
strains such as the Salmonella Enteritidis ΔhilAssrAfliG strain are cleared quickly after 
administration, it might be possible to effectively combine these. CI strains would then 
confer early protection against Salmonella challenge and after they are cleared or protection 
can be conferred by other means, administration of these other measures could commence. 
 
Another major advantage for CI is that the protective effect offered is, at least initially, of 
much larger magnitude than most other control measures available for Salmonella control in 
broilers. Administration of a CI strain can reduce caecal Salmonella colonization with several 
log units or even almost fully prevent colonization, as observed in Chapter 3.2. Other control 
measures, such as SCFA’s, MCFA’s, altered feed composition or pre- and probiotics only 
reduce Salmonella colonization and shedding to a limited extent. As such, they can help 
contribute to Salmonella reduction in poultry, but CI might have a bigger impact on 
Salmonella prevalence if implemented in practice. Resent research has shown that 
bacteriophages can also be used to control Salmonella in poultry [139, 140, 226-230]. Not 
only can these lytic phages be used to reduce intestinal Salmonella levels, they can also be 
used to reduce Salmonella contamination on carcasses and eggs [226-230]. In addition, 
bacteriophages can cause a significant reduction in Salmonella levels, up to several log units 
or even eliminate Salmonella completely. As such, bacteriophages might represent a useful 
novel tool for Salmonella control in poultry and are a possible alternative for CI as a novel 
control measure. Competitive exclusion products offer a significant level of protection as 
well, reducing Salmonella colonization levels several log units and are thus a viable 
alternative to CI too [98, 135-137]. In addition, CE products can be sprayed on the chickens 
allowing for early and significant protection, much like CI [98, 109, 138]. The only drawback 
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for these products is that they might contain pathogenic bacteria, as they are undefined 
mixtures of bacteria [98]. Thoroughly testing and analyzing these products for the presence 
of pathogenic bacteria before application can however avoid this potential threat, allowing 
for a treatment which not only protects against Salmonella but other enteropathogenic 
bacteria as well. Other measures, such as bacteriocins could possibly be a viable alternative 
to the currently applied control measures as well [231-233]. Long-term studies on the effect 
of bacteriocins on Salmonella colonization in poultry have however not been performed yet, 
but research indicates that at least one bacteriocin is capable of reducing Salmonella 
colonization by several log units in the caecum of experimentally infected broilers [233]. As 
such, bacteriocins might represent another possible alternative to protect broilers against 
Salmonella. 
 
Due to implemented control measures and control programs, Salmonella Enteritids and 
Salmonella Typhimurium prevalence in broilers has decreased considerably in Europe to the 
point that many member states have reached the target set forward by the European Union 
(< 1 % of broiler flocks positive for Salmonella Enteritidis and Typhimurium). Therefore, CI 
might be especially useful for countries where there are little control measures available or 
no control programs established and where Salmonella represents an even bigger threat for 
public health. In such countries, infection pressure on farms is often very high, which would 
reduce efficacy of some control measures. The used seeder-bird model shows however that 
CI can be used to protect broilers against Salmonella under a high infection pressure, as in 
the model a significant number of animals are inoculated with a high dose of Salmonella. 
Additionally, this seeder bird model mimics infections in the field, as the infection is allowed 
to spread within the flock after initial infection of a part of the birds, illustrating CI also can 
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be used under field conditions. In addition, all birds were treated with the CI strain prior to 
infection in the performed experiments, even the seeder birds, which resembles field 
conditions more closely if CI would be integrated in a control program. 
 
Finally, because the Salmonella Enteritidis ΔhilAssrAfliG strain and Salmonella Typhimurium 
ΔhilAssrAfliG strain are GMO’s, administration procedures preceding marketing 
authorization would be more comprehensive as compared to non-GMO strains. In the 
European Union, veterinary medicinal products containing GMO’s are subject to both 
pharmaceutical and GMO regulations before authorization is granted [234]. Nevertheless, 
there are several veterinary medicinal products containing or consisting of GMO’s available 
on the European market [234]. As such, the developed CI strains can be considered for use in 
Europe and other parts of the world as well, where administration procedures are often less 
difficult for live GMO vaccines. 
 
4.5 Future prospects 
 
The developed Salmonella Typhimurium ΔhilAssrAfliG strain cannot be used in practice due 
to safety concerns, as it is not cleared by slaughter age and its use would comprise a risk for 
food chain safety. It would however be possible to further attenuate this strain by 
introducing one or more mutations, resulting in a strain that is cleared by slaughter age. 
However, before additional genes are deleted, their role should be comprehensively studied 
in order to be able to generate a safe CI strain while maintaining its CI potential. Another 
possibility might be administering lower amounts of the strain, reducing intestinal 
colonization and expediting clearance. 
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Due to implemented control measures and control programs, Salmonella Enteritids and 
Salmonella Typhimurium prevalence in broilers has decreased in Europe for the past decade. 
Coinciding with this decrease, other serotypes such as Salmonella Paratyphi B var. Java have 
become increasingly important for broiler production and rearing. CI strains that protect 
against these increasingly more important serotypes could be developed as well, in order to 
be able to quickly respond to these possible treats for public health. This might however be 
more difficult than anticipated, as introducing the same mutations in different serovars not 
always results in the same level of attenuation. In addition, these CI strains should be tested 
thoroughly for safety and efficacy before they can be considered for use in practice. 
 
An interesting, possible prospect is investigating whether the developed CI strains can be 
used to protect laying hens as well as broilers, and whether these strains are able to induce a 
protective immune response when they are administered later in the chickens life, when the 
animals are old enough to mount an effective immune response. Both aspects could be of 
practical importance for the vaccine industry, as this would broaden the market. 
 
Another important aspect of CI that remains to be elucidated, is the underlying mechanism. 
Currently, it remains poorly understood, but it shows similarities to the inhibition effect 
observed when a strain is grown in a stationary-phase broth culture of another strain [210]. 
The effect can thus be reproduced by inoculating stationary-phase cultures of Salmonella 
with small numbers of another Salmonella strain, which results in impaired growth of this 
second strain. This approach was followed by Nógrády et al. [235], who used a transposon 
bank to produce a large number of mutants and screen these for their ability to inhibit 
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growth of a second strain. They found genes contributing to anaerobic fumarate uptake and 
generation, the anaerobic L-arginine utilization pathway and flagellin synthesis to play a role 
in the in vitro inhibition effect. However, although mutants in these genes were deficient in 
growth inhibition in vitro, they were still able to inhibit growth of a challenge strain in vivo. 
Rychlik et al. [236] used a similar approach and found other genes to play a role in the in 
vitro inhibition effect. In this study, mutations of genes involved in respiration, amino acid 
biosynthesis, chemotaxis and nutrient uptake and its regulation were shown to result in 
strains which were no longer able to inhibit growth of a challenge strain. The effect of these 
mutations was however not investigated in vivo. Earlier studies [210, 237, 238] made similar 
observations for genes playing a role in the energy metabolism and genes involved in 
quorum sensing. A possible explanation for these observations is that, when the mutant 
strain is not able to utilize a certain carbon source or a specific nutrient, it can be used for 
growth by a second strain, resulting in a growth advantage for the second strain [237]. The 
defect in growth inhibition of mutants in genes involved in motility can be explained in a 
similar manner, as mutations in these genes results in an impaired motility and thus 
chemotaxis, limiting nutrient uptake and thus growth, allowing for a second strain to 
outgrow the mutant strain. Mutations in genes involved in respiration or proton 
translocating enzymes result in impaired growth as well, as these mutants are unable to use 
certain nutrients or have an impaired electro-chemical gradient across the plasma 
membrane. In addition, these studies suggest that quorum sensing does not play a role in CI 
either. As such, it is difficult to claim with certainty that any of these genes play an actual 
role in CI in vivo and consequently, further research to elucidate the underlying mechanism 
is necessary. Currently, proposed possible mechanisms for CI in vivo include competition for 
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nutrients, competition for attachment sites in the host GIT and possibly stimulation of the 
immune system [133]. 
  
4.6 Conclusion 
 
Colonization-inhibition represents a powerful, unexploited tool that can be used to protect 
broilers early after hatching against Salmonella challenge. Not only is this the period in which 
chicks are most vulnerable for Salmonella infection, there are also no other effective control 
measures to fully protect young chicks that early in their life. In addition, it is possible to 
confer protection against multiple Salmonella serovars in a single treatment, provided the CI 
strains conferring protection against these serotypes are available. The developed 
Salmonella Enteritidis hilAssrAfliG deletion mutant strain is a safe and efficient strain and can 
consequently be used in broiler practice to help reduce Salmonella Enteritidis prevalence. 
The Salmonella Typhimurium hilAssrAfliG deletion mutant strain on the other hand, confers 
protection against Salmonella Typhmurium challenge, yet cannot be used in practice in its 
current form as it is not cleared by slaughter age. Finally, we found that CI strains should be 
administered as soon as possible in the broiler’s life, which can be done by spraying a 
solution containing the CI strain on newly hatched chickens. 
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5 Summary & Samenvatting 
 
5.1 Summary 
 
Salmonella contamination rates in poultry have declined drastically the past decade in the 
European Union thanks to the implication of member state control programs. Despite this, 
consumption of contaminated poultry meat remains an important cause of food-borne 
Salmonella infections in humans. Young chicks often become infected with Salmonella early 
in life, as they are highly susceptible to Salmonella infections due to the absence of natural 
intestinal microbiota and an underdeveloped immune system. In addition, there are no 
control measures available that effectively protect the chicks early after hatching. Therefore, 
a novel control method that protect broilers from day-of-hatch until slaughter age against 
infection with Salmonella might help contribute to further reduce of Salmonella prevalence 
in poultry. Colonization-inhibition (CI), a concept in which a live Salmonella strain is orally 
administered to day-old chickens and protects against subsequent challenge, can potentially 
be used as a novel control method to achieve this goal. 
 
Before a Salmonella strain can be considered for use as a CI strain, it needs to fulfill several 
criteria. Firstly, the CI strain should be safe, meaning that this CI strain should no longer be 
virulent, cannot revert to virulence, should be cleared by slaughter age and does not 
interfere with testing procedures. Secondly, the CI strain should be able to offer protection 
against Salmonella early in the broiler life and this protection should last until slaughter age. 
Earlier research has shown that a Salmonella Enteritidis strain with a deletion in the hilA 
gene (coding for a key regulator for the Salmonella Pathogenicity Island 1) is a CI strain that 
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offers good protection against Salmonella Enteritidis challenge, but is still being shed and 
carried by slaughter age. Similarly, a Salmonella Enteritidis with a deletion in the ssrA gene 
(coding for a key regulator for the Salmonella Pathogenicity Island 2) offers protection 
against challenge, but is not cleared by slaughter age. Combination of these mutations might 
however result in a CI strain that fulfills both criteria of safety and efficacy. Finally, live 
vaccine strains lacking flagellin can easily be differentiated from wild-type strains and allow 
for serological differentiation between treated and infected animals. Introduction of such a 
mutation could thus confer several practical advantages to a putative CI strain. 
 
The aim of this work was the development of CI strains that are safe for use in broiler 
practice and offer protection against Salmonella infection early in the chicken life. To do so, 
hilA, ssrA and fliG genes were deleted in a Salmonella Enteritidis and a Salmonella 
Typhimurium strain, after which safety and efficacy for both the resulting CI strains was 
investigated. In addition, we wanted to investigate whether simultaneous administration of 
these CI strains could offer protection against multiple Salmonella serovars. 
 
In chapter one of this work, we investigated whether a Salmonella Enteritidis hilAssrAfliG 
deletion mutant strain is safe and offers recently hatched chicks protection against 
Salmonella Enteritidis until slaughter age. To investigate safety, we orally administered the 
Salmonella Enteritidis ΔhilAssrAfliG strain to a group of one-day-old broiler chicks and 
monitored faecal shedding and both spleen and caecal colonization by the strain until 
slaughter age. In addition, hilA, ssrA and fliG single deletion mutants and a hilAssrA deletion 
mutant were administered to other groups as well, allowing for a comparison of the 
different Salmonella Enteritidis deletion mutant strains. Shedding of the Salmonella 
Chapter 5  Summary & Samenvatting 
131 
Enteritidis hilAssrAfliG deletion mutant was lower in comparison to the other deletion 
mutants, and ceased earlier; this strain was no longer shed after 21 days. Similarly, 
colonization of caecum and spleen was lower for the Salmonella Enteritidis hilAssrAfliG 
deletion mutant, and decreased rapidly after administration. It could no longer be detected 
after 28 days (well before slaughter age), indicating that the Salmonella Enteritidis 
hilAssrAfliG deletion mutant is a safe CI strain. To investigate whether the deletion mutant 
strain offers protection against Salmonella infection, we administered the Salmonella 
Enteritidis ΔhilAssrAfliG strain orally to one-day-old chicks and experimentally infected them 
with a wild-type Salmonella Enteritidis strain 24 h later in a seeder-bird model. 
Administration of the CI strain resulted in decreased faecal shedding of the wild-type 
Salmonella Enteritids strain and a significantly lower caecal colonization. This data indicates 
that a Salmonella Enteritidis ΔhilAssrAfliG strain is safe and can be used to protect chickens 
against Salmonella Entertidis infection. 
 
In chapter two of this work, we investigated whether a Salmonella Typhimurium hilAssrAfliG 
deletion mutant strain is safe and offers recently hatched chicks protection against 
Salmonella Typhimurium until slaughter age. In addition, we investigated whether 
simultaneous administration of a Salmonella Enteritidis hilAssrAfliG deletion mutant strain 
and a Salmonella Typhimurium hilAssrAfliG deletion mutant strain offers protection against 
both Salmonella Enteritidis and Salmonella Typhimurium challenge. To investigate safety and 
efficacy, we administered the Salmonella Typhimurium hilAssrAfliG deletion mutant strain 
orally to one-day-old chickens, after which the chickens were experimentally infected with a 
Salmonella Typhimurium wild-type strain. Faecal shedding and spleen and caecal 
colonization of both CI and challenge strain were monitored until slaughter age. Shedding of 
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the wild-type strain decreased rapidly when chicks were treated with the CI strain, and it 
was no longer shed after 16 days. An even stronger protection was observed in caecum and 
spleen, as treatment with the CI strain prevented the challenge strain from colonizing these. 
However, the Salmonella Typhimurium hilAssrAfliG deletion mutant strain was still being 
shed and present in the caecum by slaughter age. To evaluate whether simultaneous 
administration of two CI strains offers protection against multiple Salmonella serotypes, we 
administered the Salmonella Enteritidis ΔhilAssrAfliG strain and the Salmonella Typhimurium 
ΔhilAssrAfliG strain simultaneous to one-day-old broiler chicks. One day later they were 
challenged with a Salmonella Enteritidis, Typhimurium or Paratypi B varietas Java strain. 
Treatment with both CI strains reduced caecal colonization of the Salmonella Enteritidis and 
Typhimurium challenge strains, but not of the Salmonella Paratypi B var. Java strain. This 
data indicates that the Salmonella Typhimurium hilAssrAfliG deletion mutant strain is a CI 
strain that offers pronounced protection against Salmonella Typhimurium infection. This 
strain is however not cleared by slaughter age, and can thus not be used in practice. 
Additionally, this data shows that simultaneous administration of the Salmonella Enteritidis 
ΔhilAssrAfliG strain and Salmonella Typhimurium ΔhilAssrAfliG strain can offer early 
protection against both Salmonella Enteritidis and Typhimurium infection. 
 
In chapter three of this work, we investigated two practical application methods, drinking 
water and spray administration, that allow for early and uniform application of the 
Salmonella Enteritidis ΔhilAssrAfliG strain. To do so, we administered the strain to one-day-
old chickens by coarse spray or in the drinking water for 24 h, after which the chicks were 
experimentally challenged with a wild-type Salmonella Enteritidis strain. Faecal shedding and 
both spleen and caecal colonization of both CI and challenge strain were monitored until 
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slaughter age. Administration of the strain using a coarse spray resulted in a strongly 
decreased feacal shedding of the challenge strain, while drinking water administration of the 
CI strain only reduced shedding of the challenge strain initially. Spray administration also 
reduced caecal colonization by the challenge strain significantly for the entire duration of the 
experiment, while this was not always the case for drinking water application. This data 
shows that CI strains should be administered early in the chicks life using a coarse spray, as 
this confers best protection against Salmonella challenge. 
 
In conclusion, colonization-inhibition represents an unexploited, potentially powerful tool 
that can be used to protect broilers early after hatching against Salmonella challenge. In 
addition, it is possible to confer protection against multiple Salmonella serovars in a single 
treatment, provided the CI strains conferring protection against these serotypes are 
available. The developed Salmonella Enteritidis hilAssrAfliG deletion mutant strain is a safe 
and efficient strain and could consequently be used in broiler practice to help reduce 
Salmonella Enteritidis prevalence. The Salmonella Typhimurium hilAssrAfliG deletion mutant 
strain on the other hand, confers protection against Salmonella Typhmurium challenge, yet 
cannot be used in practice in its current form as it is not cleared by slaughter age. Finally, CI 
strains should be administered as soon as possible in the broiler’s life, which can be done by 
spraying a solution containing the CI strain on newly hatched chickens. 
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5.2 Samenvatting 
 
Het aantal Salmonella besmettingen van pluimvee is het laatste decennium drastisch 
gedaald in verschillende lidstaten van de Europese Unie door het invoeren van 
controleprogramma’s. Desondanks blijft de consumptie van besmet pluimveevlees een 
belangrijke oorzaak van door voedsel overgedragen Salmonella besmettingen bij de mens. 
Vaak worden jonge dieren besmet met Salmonella op jonge leeftijd en zijn ze op 
slachtleeftijd nog steeds geïnfecteerd, wat tot contaminatie van het vlees kan leiden. Jonge 
kippen zijn namelijk uitermate gevoelig voor Salmonella infecties doordat hun darmflora en 
immuunsysteem onvoldoende ontwikkeld zijn. Bovendien zijn er geen efficiënte 
controlemaatregelen voorhanden die kippen op dat moment kunnen beschermen tegen 
Salmonella. Een nieuwe controlemaatregel die vleeskippen beschermt vanaf het moment 
van uitkippen tot op slachtleeftijd zou echter kunnen bijdragen tot een verdere reductie van 
het aantal Salmonella besmettingen in pluimvee. Kolonisatie-inhibitie, een concept waarbij 
een levende Salmonella stam wordt toegediend aan eendagskuikens en hen vervolgens 
beschermt tegen verdere Salmonella besmettingen, zou hiervoor gebruikt kunnen worden.  
 
Alvorens een Salmonella stam kan gebruikt worden als CI stam dient deze aan verschillende 
voorwaarden te voldoen. Eerst en vooral dient deze stam veilig te zijn, wat inhoudt dat de 
stam niet langer virulent mag zijn, niet langer aanwezig mag zijn in de kip op slachtleeftijd, 
niet kan reverteren naar het oorspronkelijke virulente fenotype en niet interfereert met 
testprocedures voor Salmonella. Verder dient deze stam ook vroeg in het leven van de kip 
bescherming te bieden tegen Salmonella besmetting. Eerder onderzoek heeft aangetoond 
dat een Salmonella Enteritidis waarvan het hilA gen (een centrale regulator voor Salmonella 
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Pathogeniciteitseiland 1) gedeleteerd is goede bescherming biedt tegen Salmonella 
Enteritidis infectie, maar wordt nog steeds uitgescheiden en is nog steeds aanwezig op 
slachtleeftijd. Ook een Salmonella Enteritidis stam waarvan het ssrA gen (een centrale 
regulator voor Salmonella Pathogeniciteitseiland 2) gedeleteerd is biedt bescherming tegen 
Salmonella Enteritidis infectie, maar is ook nog steeds aanwezig op slachtleeftijd. 
Aanbrengen van beide mutaties in dezelfde stam zou echter kunnen resulteren in een CI 
stam die aan de criteria van veiligheid en bescherming voldoet. Tenslotte kunnen levende 
vaccins die geen flagellen hebben makkelijk onderscheiden worden van wild-type stammen 
en staan deze toe behandelde dieren en geïnfecteerde dieren serologisch van elkaar te 
onderscheiden. Aanbrengen van een mutatie die flagelline productie onmogelijk maakt zou 
potentiële CI stammen dus nog additionele praktische voordelen kunnen opleveren. 
 
Het doel van dit werk was de ontwikkeling van veilige CI stammen die vleeskippen reeds kort 
na uitkippen beschermen tegen Salmonella infectie. Om dit te doen werden het hilA, ssrA en 
fliG gen gedeleteerd in een Salmonella Enteritidis en Typhimurium stam, waarna veiligheid 
van en bescherming geboden door de stammen werd onderzocht. Verder werd ook 
nagegaan of de gelijktijdige toediening van deze CI stammen bescherming biedt tegen 
verschillende Salmonella serotypes. 
 
In hoofdstuk één van dit werk werd onderzocht of een Salmonella Enteritidis hilAssrAfliG 
deletie mutant veilig is en of deze kuikens vanaf uitkippen tot op slachtleeftijd kan 
beschermen tegen Salmonella infectie. Om de veiligheid van deze stam te onderzoeken 
werd deze toegediend aan één dag oude vleeskuikens, waarna caecum en milt kolonisatie en 
fecale uitscheiding van de stam werden opgevolgd tot op slachtleeftijd. Ook werden andere 
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groepen geïnoculeerd met een hilA, ssrA, fliG, hilAssrA deletiemutant of de oorspronkelijke 
wild-type stam, waardoor de veiligheid van deze deletiemutanten kon vergeleken worden. 
De Salmonella Enteritidis hilAssrAfliG deletie mutant werd steeds in mindere mate 
uitgescheiden dan de andere deletiemutanten en de wild-type stam, en hield ook vroeger 
op; na 21 dagen werd deze niet langer uitgescheiden. Verder was ook de kolonisatie van 
caecum en milt door de Salmonella Enteritidis hilAssrAfliG deletie mutant lager, en daalde 
dit snel na toediening. Deze stam kon niet langer teruggevonden worden na 28 dagen (ruim 
voor slachtleeftijd), wat aangeeft dat de Salmonella Enteritidis hilAssrAfliG deletie mutant 
een veilige CI stam is. Om na te gaan of deze stam ook bescherming biedt tegen Salmonella 
Enteritidis infectie werd de Salmonella Enteritidis ΔhilAssrAfliG stam oraal toegediend aan 
eendagskuikens, waarna deze 24 u later experimenteel geïnfecteerd werden met een wild-
type Salmonella Enteritidis stam. Dit resulteerde in een verminderde fecale uitscheiding en 
in een verminderde caecale kolonisatie van de wild-type stam. Deze data geeft aan dat de 
Salmonella Enteritidis ΔhilAssrAfliG stam een veilige CI stam is en dat deze gebruikt kan 
worden om vleeskippen te beschermen tegen Salmonella Enteritidis infectie. 
 
In hoofdstuk twee van dit werk werd onderzocht of een Salmonella Typhimurium 
hilAssrAfliG deletie mutant ook een veilige stam is en of deze stam kippen kan beschermen 
tegen Salmonella Typhimurium infectie vanaf uitkippen. Verder werd onderzocht of 
gelijktijdige toediening van een Salmonella Enteritidis ΔhilAssrAfliG stam en een Salmonella 
Typhimurium ΔhilAssrAfliG stam bescherming biedt tegen zowel Salmonella Enteritidis als 
Typhimurium infectie. Om de veiligheid en efficiëntie van de Salmonella Typhimurium 
ΔhilAssrAfliG stam na te gaan werd de stam oraal toegediend aan eendagskuikens, waarna 
de dieren al dan niet experimenteel geïnfecteerd werden met een wild-type Salmonella 
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Typhimurium stam. Uitscheiding van zowel de CI stam als de wild-type stam werden vanaf 
toediening tot op slachtleeftijd opgevolgd, alsook kolonisatie van caecum en milt. 
Behandeling met de CI stam reduceerde uitscheiding van de wild-type stam totdat deze niet 
langer werd uitgescheiden na 16 dagen. Een nog meer uitgesproken bescherming werd 
waargenomen in caecum en milt, waar de CI stam kolonisatie door de wild-type stam 
volledig verhinderde. De Salmonella Typhimurium hilAssrAfliG deletie mutant werd echter 
nog steeds uitgescheiden en was nog steeds aanwezig in het caecum op slachtleeftijd. Om 
na te gaan of gelijktijdige toediening van twee CI stammen bescherming biedt tegen 
meerdere Salmonella serotypes, werden de Salmonella Enteritidis ΔhilAssrAfliG stam en de 
Salmonella Typhimurium ΔhilAssrAfliG stam gelijktijdig oraal toegediend aan 
eendagskuikens. Eén dag later werden de dieren experimenteel geïnfecteerd met een wild-
type Salmonella Enteritidis, Typhimurium of Paratyphi B varietas Java stam. Behandeling van 
de kippen met de CI stammen resulteerde in een gereduceerde caecale kolonisatie door de 
Salmonella Enteritidis en Typhimurium stammen, maar had geen effect op Salmonella 
Paratypi B var. Java kolonisatie. Deze data geeft aan dat de Salmonella Typhimurium 
hilAssrAfliG deletie mutant een CI stam is die goede bescherming biedt tegen Salmonella 
Typhimurium infectie, maar persisteert tot op slachtleeftijd en dus niet gebruikt kan worden 
in de praktijk. Verder bleek ook dat gelijktijdige toediening van een Salmonella Enteritidis 
ΔhilAssrAfliG stam en Salmonella Typhimurium ΔhilAssrAfliG stam bescherming kan bieden 
tegen zowel Salmonella Enteritidis als Typhimurium infectie. 
 
In het derde hoofdstuk van dit werk werden twee praktisch relevante toedieningswijzen 
voor de Salmonella Enteritidis ΔhilAssrAfliG stam onderzocht en vergeleken, namelijk 
drinkwater en spray administratie. Hiervoor werd de Salmonella Enteritidis ΔhilAssrAfliG 
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stam toegediend aan eendagskuikens in het drinkwater gedurende 24 u of door de stam te 
sprayen op de kuikens, waarna ze experimenteel geïnfecteerd werden met een wild-type 
Salmonella Enteritidis stam. Uitscheiding van zowel de CI stam als de wild-type stam werden, 
net als kolonisatie van caecum en milt, opgevolgd vanaf toediening tot op slachtleeftijd. 
Toediening van de CI stam met behulp van een spray resulteerde in een sterke daling van 
fecale uitscheiding van de wild-type stam, terwijl uitscheiding van de wild-type stam enkel 
initieel daalde na toediening van de CI stam in het drinkwater. Administratie van de CI stam 
met behulp van een spray resulteerde ook in sterk gereduceerde caecale kolonisatie door de 
wild-type stam, terwijl dit niet steeds het geval was na drinkwater toediening. Deze data 
geeft aan dat CI stammen idealiter vroeg in het leven van de kippen toegediend worden met 
behulp van een spray, aangezien dit resulteert in betere bescherming tegen Salmonella 
infectie. 
 
Kolonisatie-inhibitie is een momenteel onbenutte, doch efficiënte manier om kippen reeds 
vroeg in het leven te beschermen tegen Salmonella infectie. Ook kan kolonisatie-inhibitie 
bescherming bieden tegen verschillende Salmonella serotypes in één behandeling, op 
voorwaarde dat de CI stammen voorhanden zijn. Deze CI stammen dienen zo vroeg mogelijk 
in het leven aan vleeskippen toegediend te worden, wat best kan gebeuren met behulp van 
een spray. De ontwikkelde Salmonella Enteritidis hilAssrAfliG deletie mutant is een veilige CI 
stam die vroeg in het leven van vleeskippen bescherming kan bieden tegen Salmonella 
Enteritidis infectie en zou bijgevolg in de praktijk gebruikt kunnen worden om Salmonella 
prevalentie in pluimvee verder terug te dringen. De Salmonella Typhimurium hilAssrAfliG 
deletie mutant biedt uitgesproken bescherming tegen Salmonella Typhimurium infectie, 
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maar is nog steeds aanwezig op slachtleeftijd en kan als dusdanig niet gebruikt worden in de 
praktijk aangezien deze persisteert tot op slachtleeftijd.  
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